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There is a general consensus that the physiological activity of fish oil can be
ascribable to eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid
(DHA, 22:6n-3). However, the form in which they are introduced in diet might
affect the rate of incorporation in tissue. The aim of this study was to examine the
effects of n-3 polyunsaturated fatty acids (PUFA) of different marine origin and
the incorporation of EPA and DHA in rat brain, liver and red blood cells (RBC).
Eight dietary groups received different diets, in which six were based on marine
resources (rich in n-3 PUFA), differing in the structural form of the fatty acids
(triacylglycerol (TAG), phospholipids (PL) and ethyl ester), and two diets were
based on vegetable resources (TAG and PL rich in n-6 fatty acids). The marine
diets included; salmon, seal oil or cod liver oil all rich in TAG, cod, marine PL,
and ethyl esters from commercially available n-3 capsules
After 3 weeks of feeding, animals were sacrificed and tissue fatty acid compo-
sition was determined. The fatty acid profile changed profoundly in the liver and
the RBC of animals receiving marine n-3 PUFA compared to n-6 diets, whereas
the changes in the brain were only moderate. Animals fed the marine diets showed
increased levels of EPA and DHA with a concomitant lower level of n-6 fatty
acids compared to animals fed vegetable diets. The brain and liver responded to
the structural forms of the fatty acids, whereas the RBC responded in a dose de-
pendent matter. The brain, the liver and the RBC differed in their response to the
different diets.
In conclusion, salmon, seal oil, cod liver oil and marine PL are good sources
for increasing DHA levels in brain, whereas the incorporation of EPA and DHA
from capsules containing the fatty acids as ethyl esters was poor.
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1
Introduction
Polyunsaturated fatty acids (PUFA) are long chained fatty acids containing two
or more double bonds. PUFA are grouped in two series based on the position
of the terminal double bond, being either at the 3 or 6 carbon from the terminal
omega (ω) carbon. PUFA are involved in a wide range of biological properties in
the cell, as well as precursors for conversion to metabolites regulating biological
functions. There is an augmented interest in PUFA because of their potential in
therapeutic, food and nutritional applications. PUFA occur naturally throughout
animal, plant, algae, fungi and bacteria.
At the Workshop on the Essentiality of and Recommended Dietary Intakes
for Omega-6 and Omega-3 Fatty Acids held in 1999 [1], there was consensus
of the importance of reducing the n-6 and increase the n-3 PUFA in diet of both
adults and newborns for optimal brain and cardiovascular health and function. The
workshop claimed that an increase in eicosapentaenoic acid (EPA) and docosahex-
aenoic acid (DHA) together with a reduction of vegetable oils high in linoleic acid
(LA), are necessary to reduce the adverse effects of excess arachidonic acid (AA)
and its eicosanoid products, to achieve a healthier diet in Western countries.
PUFA derived from n-6 and n-3 fatty acids (FA) are fundamental structural
components of brain membrane lipids [2]. DHA plays an important role in the
growth, development and nutrition of the brain [3, 4, 5], however the mechanisms
of DHA action in the brain is not clear. Early, perinatal, n-3 status has been
shown to profoundly affect adult physiology [6] and more investigation is needed
to establish the cellular and molecular mechanisms of DHA in the brain.
2 CHAPTER1
1.1 Omega-3 (n-3) Fatty Acids
Long-chain omega-3 (n-3) fatty acids are produced by terrestrial and marine plants.
Fish and other seafoods are rich sources of long n-3 FA with 20 and 22 carbons in
length, whereas vegetable oils, cereals and all vegetables and fruits only contain
18 carbon n-3 FA acids.
If α-linolenic acid (ALA, 18 : 3n-3) can be fully synthesized to EPA and DHA
in the human body, one could expect the same health benefits from 18 : 3n-3 rich
vegetable oil as direct intake of marine oil. This has not yet been demonstrated,
and there is little evidence that the consumption of vegetable oils rich in ALA will
have the same beneficial effect in preventing or treating chronic diseases such as
coronary heart disease [7].
Unlike saturated FA, which have been shown to have negative health conse-
quences, the polyunsaturated n-3 FA have been associated with many health ben-
efits [8]. Fatty acids of the n-3 family have been found to have a positive effect in
treating hyper-tension, Crohn’s Disease, rheumatoid arthritis, and asthma. n-3 FA
have also been reported to decrease the risk of primary cardiac arrest, coronary
artery disease and decrease serum triglycerides (see references within [8]). New
research is also suggesting a potential positive role of n-3 PUFA in a number of
psychiatric disorders [8].
1.1.1 Docosahexaenoic acid (DHA)
Docosahexaenoic acid (DHA, 22 : 6n-3), a 22 carbon n-3 fatty acid with six double
bonds (figure 1.1) is the most unsaturated membrane FA present in the mammalian
biological system [9]. Dietary DHA can only be found in marine foods such as
fish and other sea life, where it has been synthesized by the phytoplankton of the
waters.
DHA is very tissue specific, compared to arachidonic acid (AA, 20 : 4n-6)
that is distributed in relatively large amount in most tissues [10]. Nervous tissue
and reproductive organs are unique in their phospholipid composition, their cell
membranes contain large amounts of n-3 FA, particularly in synaptic membranes
in gray matter [11, 12], especially synaptic membranes [13], and in the rod outer
segment in retina [4, 14]. The rod outer segment in retina contains the highest
level of DHA in the human body. Up to 50 % of the membrane phospholipids are
n-3 PUFA, most of which is DHA. [3, 10].
Adequate supply of long-chain polyunsaturated fatty acids (LCPUFA) in has
shown to be important in infant mental development [15]. DHA is especially
important during prenatal human brain development. Both the placenta, and breast
feeding supply predominantly DHA and AA to growing infants [15]. DHA in
infant diet is associated with higher mental development scores [16], better visual
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acuity as measurement of infant brain maturation [17], and better problem-solving
scores [18].
Upon deficiency of n-3 FA, a decrease in the levels of DHA are followed by
an increase in the end products of the n-6 metabolism, DPA n-6 [19]. DPA n-6
will accumulate to a certain degree instead of DHA [20, 21], in order to keep the
total content of 22 carbon FA constant. How well the content of LCPUFA is kept
stable depends on the tissue [5]. The LCPUFA are kept at a more stable content
in the brain and retina than other tissues [22], and the DHA concentration in these
areas are little influenced by diet. The brain and retina have efficient conservation
mechanisms to preserve a constant high level of DHA in their membranes [3, 23].
Neurons and astrocytes are reported [21] to be kept most constant with respect to
n-3 / n-6 ratio, whereas the long-chain PUFA content seems to be tightly regulated
in synaptosomal membranes and oligocytes.
Figure 1.1: Structure of the n-3 fatty acid docosahexaenoic acid (DHA), the most unsaturated
fatty acid present in the mammalian biological system, containing 22 carbon and 6 double bonds.
1.2 Polyunsaturated Fatty Acids and Central Ner-
vous System
PUFA are known to constitute an important environmental factor in the central
nervous system (CNS). The CNS contains large amounts of DHA and AA, which
mainly accumulate during the brain growth spurt [24]. The CNS requires large
amounts of DHA during early postnatal development, when cellular differentia-
tion, active synaptogenesis, and photoreceptor membrane biogenesis takes place
[25]. DHA is a ubiquitous and essential component of the CNS, and the high
content, specific incorporation and strong retention within nervous tissue strongly
suggest that DHA play a specific role, and is an important compound for optimal
brain function [26]. Studies on n-3 FA have shown that long-chain PUFA defi-
ciency in rats pertubates the learning behavior and performance in several learn-
ing tasks involving learning abilities, and sensory, motor or motivational processes
[27, 28]
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1.2.1 Polyunsaturated Fatty Acids and the Brain
Lipids account for about 10 % of the fresh weight and 50−60 % of the dry mat-
ter of the brain [29]. 35 % of the lipids are found as PUFA, mostly long-chain
PUFA. DHA constitutes almost 17 % by weight of the total FA in the brain of
adult rats, and 33 % of total FA in the retina, but only a small percentage in other
tissues of the body. The PUFA in the nervous system participate in the structure
of phospholipids, but not that of sphingolipids [29]. Brain lipids are mainly struc-
tural, and they are not related to energy metabolism; they participate directly in
the functioning of cerebral membranes [30]. The lipids are mainly found in nerve
cell membranes as complex lipids. The cerebral essential FA can either be derived
from the dietary precursors, linoleic acid (n-6) andα-linolenic acid (n-3) by inter-
mediary metabolism in the body, or originate from diet rich in long-chain PUFA,
e.g. seafood. The most prominent FA in the brain are of 20- and 22-carbon atoms,
and the most common FA in phospholipids are AA (20 : 4n-6) and DHA (22 : 6n-
3). These long-chain PUFA are important for the structure and function of many
membrane proteins, including receptors, enzymes and active transport molecules.
The biochemical effects induced by dietary LCPUFA on the cellular membranes
may result in functional changes including alteration in membrane architecture
and fluidity [31], enzymatic activities [11] and ion transport [32], membrane elec-
trophysiology [32] and gene expression [33, 34].
During embryonic and postnatal development of the nervous system, long-
chain PUFA, especially DHA and AA, accumulate in retina and synaptic mem-
branes in the brain [4]. The largest accretion of PUFA takes place during the last
trimester and the first 6−10 months after birth in humans, when the brain growth
spurt is taking place [24]. The fetus recieves PUFA through the placenta and the
newborn mammal from the maternal milk. Human infants requires an adequate
supply of n-6 and n-3 fatty acids in order to sustain development of neurological
structures of the brain and retina, and to support normal growth and develop-
ment of other tissues [10]. Preterm infants have shown the ability to synthesize
long-chain PUFA from 18-carbon precursors [35], but more research is needed to
establish whether these metabolic systems capacity proceeds at a sufficient rate to
meet tissue needs for DHA.
The identification of important developmental periods in the ontogeny of brain
membrane lipids, especially regarding the supply of essential FA influenced by
extrinsic factors to the brain, such as nutrition and maternal -placental circula-
tion, suggests vulnerable time points at which events that disrupt the normal on-
togenetic pattern of accumulation could produce long-lasting effects on normal
development [36]. The developing brain appears to be more susceptible to di-
etary changes than the adult brain [27, 37, 38, 39]. The total fatty acid content in
the brain augments 4−5 times during brain maturation due to rapid accretion of
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lipids. After maturation the fatty acid composition remains fairly constant [29].
There are many reports on the effect of n-3 PUFA deficiency, but few on the
supply of DHA and learning abilities. Chronic administration of DHA has shown
to improve reference memory∗-related learning ability in young [40] and aged
rats [41]. Diets containing long-chain n-3 PUFA affect the fatty acid profile of the
brain [42] and cognitive functions [43, 44, 45].
The fatty acid profile in the brain can be recovered from n-3 FA deficiency as
shown in rats [46], and monkey [47], but the rate is very slow compared to other
tissues [46, 48, 49]. The slow recuperation rate may be that regulation occurs at
the level of either synthesis in liver, transport across the blood-brain barrier, or
the enzymatic activities of desaturation and elongation [50]. It is interesting that
the recuperation rate of cerebral microvessels and capillaries also were slow [51],
even though they are in contact with plasma lipoproteins of normal composition,
since the liver recuperates very rapidly (2 weeks).
Hippocampus
The hippocampus is a bilateral, cortical structure located in the temporal lobe (fig-
ure 1.2). The hippocampus is an important structure in learning and consolidation
of explicit memories†, from short-term memory to long term memory storage
in other cortical regions. Damage to the hippocampal complex can lead to irre-
versible anterograd amnesia‡ [52]. Although the mechanisms of DHA in memory
formation are unclear, results strongly suggest that the ratio of DHA/AA in differ-
ent cerebral structures, like the hippocampus, may be considered a novel indicator
of learning ability [40, 41].
DHA may be involved in protection against neuronal degenerative stress. Lipid
peroxide (LPO) from peroxidation of PUFA are know to damage genes, mem-
brane lipids and enzyme proteins. The accumulation of LPO induces disorders
of cellular function in the aging. Chronic administration of DHA decreases LPO
levels in the hippocampus [41], as well as reduces neural damage after forebrain
ischemia, probably due to an increase in the DHA/AA ratio in the hippocampus
[9].
DHA and Long-term potentiation DHA does not only have neuronally pro-
tective effects on the hippocampus, it also exerts direct effects. DHA has been
suggested to plays an important role in long-term potentiation (LTP). LTP is a
∗Reference memory involves utilizing information that remains constant over time
†Explicit memory involves memories based on facts and events
‡Anterograd amnesia refers to the inability to form new memories following brain trauma. In
severe cases a person may be completely incapable of learning anything new
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long-lasting, activity-dependent change in the efficacy of synaptic communica-
tion. Since its discovery by Bliss and Lømo [53] in 1972, LTP has been a well
studied example of synaptic plasticity§. This phenomena is regarded as a neu-
ronal base of learning and memory, and is believed to provide information re-
garding the understanding of the cellular and molecular mechanisms involved in
forming and storing of memories in the brain. LTP has been well documented in
the hippocampus, where it is induced by activation of theN-methyl-D-aspartate
(NMDA) receptor.
Figure 1.2: 3D positioning of the hippocampus (yellow) in rat brain. Adapted from Synapse
Web, Medical College of Georgia, http://synapses.mcg.edu/
1.3 Mental Health
Major depressive disorder is a recurrent illness leading to severe impairment of
the persons mental health [54]. Despite advances in pharmacotherapy, a signif-
icant proportion of depressed patients are resistant to treatment [55]. There has
been little focus on the nutritional influences on depressive symptoms, and new
research indicates that dietary influence on mental disorders is currently underes-
timated. Research is now showing growing evidence for n-3 as a new potential
agent in the treatment of depression [56].
According to the World Health Organization (WHO) [54] 25 % of the people,
in both developed and developing countries, will experience one or more men-
tal or behavioral disorders at some stage in life. 450 million people worldwide
are affected by mental, neurological or behavioral problems at any time. WHO
estimates that 121 million people are currently suffering from depression, and
870.000 people die by suicide every year. Even though depression can be reliable
diagnosed and treated in primary care, less than 25 % of those affected have ac-
cess to effective treatments.One of the barriers to an effective treatment of mental
§Synaptic plasticity is defined as changes in synaptic strength and modification
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illness is the lack of recognition of the seriousness of the illness. There is a dis-
crimination between physical and mental problems at all levels of society; from
politicians, insurance companies to the public at large. [54].
Major Depression Disorder (MDD) Depression is a common mental disorder.
It is an extremely complex and heterogeneous condition, not to be misconceived
with normal mood changes. A major depressive episode is a pathological mood
state in which persistent negative emotions and thoughts coexist with disturbances
of motivation, sleep, energy, appetite, and libido. MDD is ranked fourth as a
cause of disability by the WHO [54], and by 2015 its ranking is expected to rise
to second! Today, depression is already the second cause of disability in the age
category 15−44 years for both men and women .
Attention Deficit Hyperactivity Disorder (ADHD) ADHD is the most com-
mon mental disorder in children. The symptoms of ADHD appears early in a
child’s life and can persist into adulthood. The disorder manifests as a persistent
pattern of inattention, hyperactivity, and impusitivity that is more frequent and se-
vere than normally observed in individuals at a comparable level of development.
These behaviors may severely affect school performance, family relationships,
and social interactions. If untreated, ADHD can have long term adverse effects
into adolescence and adulthood, and over time children with ADHD may develop
depression, poor self-esteem and other emotional problems. There is no specific
test for diagnosing ADHD, hence making an accurate diagnosis is difficult, es-
pecially in adults. There is no recent cure for ADHD, however, medications can
improve the condition, and is an important part of the treatment. In the recent
years ADHD has been a subject of great public attention and concern.
In Norway, it is estimated that 5−6 % of all children have ADHD, whereas
2−3 % of these have a severe degree of the disorder. 300.00 children between
6− 18 years of age has been diagnosed with ADHD, and about 50 % of these
outgrows the disorder. ADHD is 2−3 times more common in boys than it is in
girls [57].
A study [58] found that boys with lower levels of n-3 FA in plasma showed,
more problems with behavior, learning and health than boys with higher level
of n-3. ADHD is believed to be a multifactorial disorder, with both genetic and
environmental etiologies. Among the factors assessed, essential fatty acid status
is a factor that may have both genetic and environmental origins [58].
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1.3.1 Nutrition and Mental Health
The rates of major depression have increased and the age of onset has decreased in
every decade during the last century [59]. The modern US and Western European
diet has changed dramatically over the past hundred years. In the 20th century in
particular, the consumption of dietary lipids has increased almost exponentially .
In addition, the type of fats consumed has changed. In the pre-industrial period,
the diet contained a balance of n-6 and n-3 FA. Advances in agriculture and food
technology have lead to a diet enriched with n-6 FA, e.g. from commercial and
processed vegetable oils, at the expense of the n-3 FA. The n-3 and n-6 FA often
have opposing physical effects, and the result of the lipid imbalance in modern
diets could be pathophysiological states mediated by these lipids [60].
Epidemiologic data suggest that populations with lower n-3 fatty acid con-
sumption, and hence, lower plasma and presumably, tissue contents of n-3 FA,
have higher rates of psychiatric disorders [61]. The identification of nutritional
factors that correlate with the prevalence rates of psychiatric disorders might pro-
vide new strategies for treatment and prevention. Long-chain n-3 PUFA, like
DHA and EPA, are important candidates in the study of nutritional insufficiencies
that may augment the risk of psychiatric disorders [62]. Greater rates of seafood
consumption are assosiated with lower lifetime prevalence rates of bipolar dis-
orders [62]. A causal relationship between seafood intake and bipolar disorder
has not been demonstrated. Nevertheless, there is a hypothesis that an insufficient
dietary intake of n-3 PUFA increases the risk of affective disorders [63].
Several authors have reported of altered fatty acid composition in plasma [58,
64, 65, 66] and erythroytes (red blood cells) [67, 68, 69] among subjects with
mental disorders compared with healthy subjects. The subjects with psychriatic
disorders show lower concentrations of EPA or DHA, together with higher ratio
of n-6 to n-3 PUFA. It must be noted, that there is a possibility, that the plasma
phospholipid level of DHA is a poor reflector of brain or synaptic DHA content,
as reported in piglets [70].
In a study [71] with rats fed fish oil, the results suggested that a lifelong in-
take of fish oil was able to induce an antidepressant effect, with EPA and DHA
concentrations increased in the cerebral cortex and hippocampus. New evidence
indicate that treatments affecting phospholipid metabolism and membrane fluid-
ity may have an effect in the treatment of depressive-like symptoms in humans
[72]. It has been found that both dietary n-3 and uridine, a stimulant of cytidine
5′-diphosphocholine which is a critical substrate for phospholipid synthesis, have
antidepressant-like effects in rat. Moreover, supplement of n-3 during 8 weeks,
seems to improve the short-term course of illness in patients with major depressive
disorder [73]
The advantages of n-3 FA as mood stabilizers include the lack of toxicity, high
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patient acceptance, have no documented adverse drug interactions, and appears to
be safe, as well as possibly beneficial, in pregnancy and children. The disadvan-
tage of n-3 in the treatment of psychiatric disorders include their low potency,
resulting in relatively large doses needed. High doses have been shown to induce
mild gastrointestinal distress and increased bleeding time [60].
Increasing evidence shows that a correct balance between n-3 and n-6 fatty
aics in brain cell membranes is important to mental health, however, more data
are required to reach conclusive answers in this regard [15].
1.4 Lipids
Lipids occur throughout the living world in microorganisms, higher plants and
animals. They occur in all cell types where they contribute to cellular structure,
provide and store fuel, and participate in biological processes ranging from tran-
scription of the genetic code to regulation of vital metabolic pathways and physi-
ological responses.
Lipids are a heterogenous group of compounds related more by their physical
rather than their chemical properties. They are based on their solubility properties
than their chemical structure. Lipids include fatty acids, triacylglycerides (TAG),
steroids, prostaglandins, fat-soluble vitamins, oils, waxes and related compounds,
all having common properties of being insoluble in water, and soluble in nonpo-
lar solvents. Lipids have four major biological functions; (1) they are the major
structural elements of membranes in all cells, (2) the triacylglycerols serve as the
main energy storage, (3) many of the vitamines and hormones found in animals
are derived from lipids, and (4) the bile acids help to solubilize the other lipid
classes during digestion. Most of the fatty acid synthesis occurs in the cytoplasm
of the liver. From there they are released into the circulation and taken up by other
tissues. Adipose tissue synthesizes triglycerides from glycerol and FA, whereas
phospholipids (PL), necessary for membrane biosynthesis, are produced by most
tissues [74].
1.4.1 Fatty Acids
Fatty acids (FA) are the simplest of the lipids. They have a chain-like structure
with an acid or carboxyl group (COOH) at one end, and a methyl group (CH3)
at the other. The rest of the molecule consists of a hydrocarbon chain varying
in length. Figure 1.3 shows the essential features of a fatty acid. Most FA are
straight-chain compounds containing an even number of carbon atoms. FA are
usually found as components of complex lipids esterified through the carboxyl
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carbon to various alcohols such as glycerol, ethanolamine, or choline, and are
rarely found as free fatty acids.
Saturation
Fatty acids can occur at different levels of saturation. A saturated fatty acid con-
tains no double bonds, whereas an unsaturated fatty acid will contain one or more
double bonds. Based on the number of double bonds, unsaturated FA are further
subdivided into monounsaturated fatty acids, containing only one double bond,
and polyunsaturated, containing two or more double bonds. Unsaturated FA are
found in plants and animals, and most concentrated in seeds, nuts, certain fruits
and fish.
Chain length
Short-chain FA have less than 8 carbon atoms, they are water soluble and absorbed
directly from the intestine into the bloodstream. They are usually metabolized for
immediate energy needs, and are most commenly found in dairy products.
Fatty acids with more than 12 carbon atoms are considered long-chain. Long-
chain FA are the major components of the complex lipids present in the mem-
branes. They are stored as phospholipids and TAG in membranes where they
serve as an efficient source of energy, or are available as precursors for several
metabolic pathways.
Figure 1.3: Essential features of a saturated fatty acid (stearic acid, 18 : 0). A fatty
acid consists of a hydrocarbon chain that may vary in length and saturation, a carboxyl
group (COOH) at one end, and a methyl group at the other (CH3). Modified from
http://medlib.med.utah.edu/NetBiochem/FattyAcids/31.html
Fatty Acid Nomenclature
Most FA have a trivial name in addition to a name given by International Union
of Pure and Applied Chemistry (IUPAC). IUPAC names follow the nomencla-
INTRODUCTION 11
ture conventions of the Recommendations of 1976, Commission on biochemical
Nomenclature [75, 76]. According to this system the names describe the structures
in detail; carbon atoms are numbered from the carboxyl carbon (carbon number
1). The carbon atom adjacent to the carboxyl carbon is know as the alpha (α)
carbon, and the terminal methyl carbon is know as omega (ω) carbon. There are
various conventions used for indicating the number and positions of double bonds;
i.e.,∆9 indicates a double bond between carbon atoms 9 and 10, counting from the
carboxyl end of the fatty acid, andω6 indicates a double bond on the sixth carbon
counting from theω-carbon atom. The omega nomenclature is the most commen
nomenclature used in the field of nutrition. The term n- is synonymous with the
use ofω, and in this thesis all FA will be denoted by omega nomenclature, us-
ing n- for the indication of the first double bond from theω carbon. Table 1.1
shows the most common unsaturated FA. They are listed by their numeric name;
indicating the number of carbon atoms in the carbon chain and total number of
double bonds (if any, separated by a colon), series, their trivial name, and where
they most commonly occur.
Table 1.1: Some unsaturated fatty acids of physiologic and nutritional significance
Numeric name Series Trivial name Occurence
16 : 1n-7 n-7 Palmetoleic in nearly all fats
18 : 0 saturated Stearic common in all animal and plant fats
18 : 1n-9 n-9 Oleic most common fatty acid in natural fats
18 : 2n-6 n-6 Linoleic corn, peanut, soybean and many plant oils
20 : 4n-6 n-6 Arachidonic found in animal fats and in peanut oil
18 : 3n-3 n-3 α linolenic particularly in linseed oil
20 : 5n-3 n-3 Eicosapentaenoic fish oils
22 : 5n-3 n-3 Docosapentaenoic fish oils, phospholipis in brain
22 : 6n-3 n-3 Docosahexenoic fish oils, phospholipids in brain
Essential Fatty Acids
Linoleic acid (LA, 18 : 2n-6) andα-linolenic acid (ALA, 18 : 3n-3), as shown
in figure 1.4, are classified as essential fatty acids (EFA). The body cannot syn-
thesize themde novo, and they must therefore be obtained through food sources
providing them “ready-made”. Both LA and ALA are needed for optimal growth
and good health, and without them deficiency symptoms (dermatis [77], growth
retardation [78] and infertility [79]) can occur. Both LA and ALA are precursors
of the n-3 and n-6 PUFA. LA is required for the synthesis of arachidonic acid,
a key intermediate in the synthesis of eicosanoids, whereas ALA is used partly
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as a source of energy, and partly as a precursor for metabolites and longer chain
PUFA.
In a normal diet LA and ALA synthesized by plants are the major source
of EFA. Within the human body 18 : 2n-6 and 18 : 3n-3 can be elongated and
desaturated to more unsaturated FA, principally arachidonic acid (20 : 4n-6) and
DHA (22 : 6n-3) [80] as shown in figure 1.5. The liver is the primary site for
essential fatty acid metabolism. Since vertebrates cannot insert double bonds more
proximal to the methyl end than the seventh carbon, once ingested, the n-3 and n-6
fatty acids are not interconvertible [5]. All metabolic conversions of EFA occur
without altering the methyl end of the molecule containing the n-3 and n-6 double
bond. However, the degree of conversion of the EFA to long-chain PUFA in the
human body appears to be unreliable and restrict [80].
n-3 and n-6 substrates compete for the same enzymes in the metabolic pathway
described in figure 1.5 to their respective long-chain PUFA. In 1963 Mohrhauer
and Holman [81] proposed a general hypothesis; all FA compete with essential
FA, at all steps of the cascade shown in figure 1.5 for metabolism of the essential
fatty acids. In their study [81], it was shown that if dietary 18 : 3n-3 is augmented,
it acts as a strong suppressor of n-6 fatty acid metabolism, whereas an equal sup-
pression of n-3 metabolism requires more than 10 times as much 18 : 2n-6 . Nev-
ertheless, equality of competition may not be the cirterion for optimal function.
It appears that the dietary ratio of 18 : 3n-3 / 18 : 2n-6 is a more important factor
than the absolute quantities of these FA for brain bioavailability, and the central
nervous system-mediated effects. The optimal ratio ofα-linoenic to linoeic acid
is ranging from 3.5 : 1 to 5 : 1 [82].
Figure 1.4: The essential fatty acids 18 : 3n-3 and 18 : 2n-6.α-linoleic acid (18 : 3n-3)
is a precursor of the n-3 LCPUFA, containing 3 double bond, the first at the third carbon
atom from the omega (ω) end. Linoleic acid (18 : 2n-6), is a precursor of the n-6 LCPUFA,




Phospholipids are the major constituents of membranes. They consitute about 50
% of the mass of most animal cell membranes, the rest being mostly proteins. In
the dry weight of the human brain 22 % of the cerebral cortex and 24 % of the
white matter consist of phospholipids [3]. Phospholipids are derivates of triacyl-
glycerols, in which one fatty acid has been replaced by a phosphate group (PO4−).
A phospholipid molecule consists of a hydrophilic polar head, and a hydrophobic
tail. The polar head can contain one or more phosphate groups. The tails are usu-
ally made up of two fatty acid chains, varying in length (normally between 14 and
24 carbon atoms) and saturation. One of the tails is usually unsaturated (contain
cis-double bonds), while the other tail is saturated. The difference in length and
saturation of the fatty acid tails are important features because they influence the
fluidity of the phospholipid molecule. A higher degree of unsaturation result in
higher fluidity.
Most phospholipids in cell membranes belong to phosphoglycerides. Phos-
phoglycerides are also the most abundant phospholipid group in neural mem-
branes [29]. They are formed from the combination of glycerol, two fatty acids,
and phosphoric acid. Phospholipids can be further modified by the covalent bind-
ing of additional compounds in the phosphate group. The addition of another
small hydroxyl-containing molecule, such as choline, serine, or ethanolamine,
creates more complex phospholipids. Some phopholipids contain a long-chain
fatty alcohol rather than a fatty acid at carbon number 1 of glycerol, such as the
plasmalogens. Plasmalogens are important structural compounds in nervous tis-
sue, and they function as a reservoir for second messengers. They may also act as
antioxidants and protect the cells from oxidative stress. Decreased levels of plas-
malogens are observed in several neurological disorders, including Alzheimer’s
disease [84]. Sphingolipids are another group of complex phospholipids, com-
posed of the amino alcohol sphingosine plus carbohydrate. The sphingolipids oc-
cur in particularly large concentrations in nervous tissue, and are the major lipid
of the myelin membrane, where they play an important role in signal transduction
processes [29].
1.5 Dietary Lipids
Triacylglycerols (TAG) are quantitatively the most important lipid component in
the human diet, and constitute the major energy contribution from lipids. Dietary
TAG is digested and absorbed, under normal circumstances, with more than 95 %
efficiency.
The digestion and absorption of dietary lipids takes place in the small intes-
14 CHAPTER1
Figure 1.5: Metabolic pathways for n-3 and n-6 fatty acids. The precursor FA, linoleic acid
andα-linolenic acid are metabolized to the longer FA through a series of enzymatic desaturation
(adding of double bonds) and elongation (adding a 2-carbon unit) steps in the endoplasmatic retic-
ulum. The mechanism of conversion of 22 : 5n-3 og 22 : 6n-3 is not agreed upon. Traditionally, it
was believed to occur via a the∆4-desaturase, however no proof of the existence of this enzyme
has been found. Currently, it is believed that the last step in the conversion of DHA occurs via a
step of retroconversion, including a desturation, an elongation step and peroxisomalβ -oxidation
reaction, as proposed by Sprecher and coworkers [83].
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tine. Lipid droplets enters the small intestine from the stomach where they are
subjected to the action of pancreatic lipase, phospholipase A2 and cholesterol es-
terase. These enzymes hydrolyse triacylglycerol to produce monoacylglycerols
and fatty acids, phospholipids to produce lysophospholipids and FA, and choles-
terol esters to liberate cholesterol and FA, respectively. These products are emul-
sified with bile salts (from the gall bladder) to produce a micellar suspension from
which components are absorbed across the epithelial cell membranes. Within the
epithelial cell, the components are reassembled and packaged into chylomicrons.
The chylomicrons do not enter the plasma directly. They are secreted into small
lymph vessels, from where they pass via the thoracic duct and enter the circu-
lation in the subclavian vein. They then reach the heart for distribution around
the body. Chylomicrons are the main route for the transport of dietary long-chain
fatty acids. Short- and medium-chain FA with chain lengths of less than twelve
carbon atoms are absorbed in the non-esterified form. They pass directly into the
portal blood and are metabolized directly in the liver. Bile salts are re-absorbed
along with cholesterol in the lower part of the small intestine [74]. The digestion
and absorption of lipids are shown in figure 1.6.
Figure 1.6: The digestion and absorption of dietary fat in the small intestine. To be usable by
the body, dietary fats must be digested in the lumen of the small intestine. The digestion products
pass through the intestine wall and are re-synthesized in the intestinal epithelial cells from where
they are packaged for transport and sent into the bloodstream. Modified from [? ]
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1.5.1 Pancreatic Lipase
Pancreatic lipase is a water-soluble, exocrine enzyme secreted by the pancreas
into the duodenum following a hormonal response. The enzyme is responsible for
the hydrolization of triacylglycerol to free fatty acids within the small intestine.
Pancreatic lipase is position specific, that is, it removes two FA from thesn-1 and
sn-3 positions (first carbon and third carbon respectively) of the TAG molecule,
leaving two free fatty acid and a monoacylglycerol (sn-2-MAG). After complete
degradation of TAG there is a general conservation of approximately 75 % of the
FA located in thesn-2 position (middle carbon) [85]. DHA in fish or fish oil TAG,
is usually located in thesn-2 position, while EPA show greater preference forsn-2
andsn-3 positions, with small amounts insn-1. By contrast, marine mammals dis-
tribute EPA and DHA in their TAG mainly insn-1 andsn-3 positions. Therefore,
the position of the FA within the TAG molecule determines the susceptibility to
hydrolysis by pancreatic lipase in the intestine, being mainlys -1 andsn-3 spe-
cific. FA in the sn-2 position are generally not substrates for intestinal lipases
[7].
1.6 Statistics
1.6.1 Principal Component Analysis (PCA)
Principal component analysis (PCA) is a multivariate technique for reducing ma-
trices of data to their lowest dimensionality. PCA involves a mathematical proce-
dure for transforming a number of possible related variables into a smaller number
of uncorrelated variables (principal components). Principal component 1 (PC1)
accounts for as much as possible of the variability in the data set. It is taken to be
along the direction with the maximum variance. Principal component 2 (PC2) is
constrained to lie in the subspace perpendicular to PC1. Within that sub-space, it
points in the direction of the maximum variance. Principal component 3 (PC3), if
any, is taken in the maximum variance direction in the subspace perpendicular to
the first 2 principal components.
1.6.2 Analysis of Variance (ANOVA)
The purpose of the analysis of variance (ANOVA) is to test differences between
means for statistically significance. This is accomplished by analyzing the vari-
ance, that is, by partitioning the total variance into the component that is due to
true random error, and the components that are due to differences between the
means. The comparison between the actual variation of the group averages and
that expected is expressed in terms of theF ratio. F= (found variance of the group
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average)/(expected variation of the group average). If the null hypothesis (H0) is
correct one could expect theF value to be about 1, whereas a “large”F indicate a
treatment effect. If the treatments are found to be significant, that is, values laying
within 95 % confidence interval, it implies that the means differ more than would
be expected by chance alone. When the treatments are significant, the means must
then be examined in order to determine the nature of the effect, and a“post-hoc
test” is used to tell where the differences in the data lies.
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1.7 Aims of the study
The molecular mechanisms underlying the positive effects of n-3 polyunsaturated
fatty acids are not fully understood, however before these mechanisms can be
fully elucidated, it is important to know the extent to which different sources of
n-3 fatty acids are incorporated into different body organs. It will be important to
know whether incorporation varies with the source and polyunsaturated fatty acid
composition of the dietary sources, an issue that has only been studied to a limited
extent.
There is a general consensus that the physiological activity of fish oil is ascrib-
able to EPA and DHA. However, the form in which they are introduced and the
rate of incorporation following the structural form administered, is less known.
This study was based on the lack of data comparing different sources of marine
n-3 fatty acids. Based on a literature review, this study is the first research aim-
ing at comparing triacylglycerols, to ethyl ester and phospholipid from different
commercially available supplements of marine n-3.
The general aim of this study was to investigate 8 different dietary supple-
ments originating from various sources, differing in the structure of the fatty acids,
to changes in fatty acid profile in brain, liver and RBC. Finally it must be pointed
out that the emphasis of this work was on brain tissue, for further interest and
investigation concerning marine n-3 and mental health.
This study addressed the following specific questions:
• Can the fatty acid profile in brain liver and RBC be changed by dietary
means during 3 weeks of feeding.
• Can the level of EPA and DHA in brain, liver and RBC be increased by
dietary means by 3 weeks of feeding.
• Do different structural forms, i.e., TAG, ethyl ester and phospholipid, of n-
3 affect the incorporation of EPA and DHA differently, in brain, liver and
RBC.
• Do different positioning of the fatty acids in the TAG molecule affect the




Male Wistar rats (initially weighing 200 g, Tactonic, USA) were housed five per
cage (Makrolon IV, Tecniplast Gazzada, Italy) for the first days of the habitua-
tion period. After three days of habituation, the rats were housed two per cage
(Makrolon III) and maintained at this arrangement during the experiment. During
the habituation period, the rats were fed on normal laboratory chow (Special Diet
Service, Witham Essex, England). The animals were kept in a 12 h light/dark cy-
cle at 22◦C and 50 % humidity, for the entire period. Cage and bedding (Beekay
Aspen chips, Hull England) were changed once a week.
The protocol was in compliance with the Norwegian Animal Research Au-
thority.
2.1.1 Study Design
The animals were randomly assigned to eight dietary groups of 6 rats per treat-
ment, recieving either n-3 or n-6 enriched diets. The selection of 6 rats per treat-
ment was based on the consideration given by the Analytical Methods Committee
(1994) [86], and a recent published report by NIFES [87]. Each group was fed
one of the diets listed in table 2.1. Each cage recieved 50 g chow per day, and the
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animals had free access to their respective diets during the 21-days experimental
period. Water was availablead libitum. The rats were weighed and daily food
intake was measured every day during the experimental period. The animals were
deprived of food 24 h before being sacrificed.
Table 2.1: Animal groups, diets and structural form of n-3 FA
Group Diets Form of n-3
A Soy oil TAG
B Salmon TAG
C Cod PL
D Ethyl ester EE
E Marine phospholipid PL
F Soya lecitin PL
G Seal oil TAG
H Cod liver oil TAG
TAG: triacylglycerol, PL: phospholipid, EE: ethyl ester
2.2 Preparation of the Diets
All diets were prepared with approximately 20 % protein (casein, Sigma), 10 %
fat (different sources), 20. 5 % basal mix (NIFES, Norway) and 50 % carbohy-
drates (dextrin, Sagogryn, Asko Hannevik AS). The amount of each ingredient
added to the respective diets is given in table 2.2. The diets were equivalent in
overall protein, fat, ash, dry matter, carbohydrate and caloric content, and the ex-
act composition of the experimental diets is listed in table 2.3.
Table 2.2: Amount of ingredients added to the diets
(g/kg diet)
Diet
Ingredient Soy Salmon Cod EE MPL Soy lec Seal oil Cod liver oil
Casein 224 66 66 224 224 224 224 224
Basal mix1 234 234 234 234 234 234 234 234
Fat (n-3 source)2 100 2463 1483 33 57 100 100 100
Maiz Oil - - 98 75 43 - - -
Dextrin 475 487 488 467 475 475 475 475
1see appendix table 5.1 for basal mix composition,2n-3 source; fish filet, oils, ethyl ester, marine phospholipid,
soy lecitin.3fish filet added. EE: ethyl ester, MPL: marine phospholipid, Soy lec: soy lecitin.
Each diet contained a different source of fat. The n-3 was given as either
triacylglycerol (TAG, diet B, G and H), phospholipids (PL, diet C, E and F) or
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ethyl esters (EE, diet D). In diets where then-3 source did not count for 10 %
of required fat, maiz oil was used as a neutral lipid source, due to no content of
long-chain n-3 fatty acids.
The two fish diets (diet B and C) were balanced on protein, due to the different
amount of fat in salmon and cod, (13.4 g / 100 g fish, and 0.3 g / 100 g fish
respectively). Diet D and E were balanced on the amount of n-3 fatty acids EPA
and DHA (2.5 g/kg/day), calculated from the amount of these fatty acids in 10 %
seal and cod liver oil (diet G and H). Diets A, G and H contained equal amount of
oil (10 % fat of total diet). All the diets were prepared before starting the feeding
and stored at−10◦C during the experiment. The fatty acid composition of the
diets is shown in table 2.4.
Table 2.3: The overall composition of the different diets, regarding protein, energy, ash,
dry matter and fat.
Diet Protein Energy Ash Dry matter Fat
(%) (J/g) (%) (%) (%)
A 21 19145 3.2 93 9.9
B 21 18910 3.4 94 9.7
C 20 18932 3.6 94 10.4
D 21 19011 3.2 93 10.7
E 22 18375 4.2 93 7.5
F 22 18204 3.9 93 4.0
G 21 19221 3.2 94 10.3
H 21 19081 3.2 93 10.4
Diet A In diet A, commercially available soy oil (Mills Soya Olje), purchased
at the local super market (Rema 1000) was used. The oil was added to the dry
mixture of casein, dextrin, and basal mix and blended using a Crypto Peerless EF
20 blender.
Diet B and C Diet B and C contained salmon and cod respectively, bought at
Strandkaien Fisk A/S fish store in Bergen. The fish were filleted, and grinded by
the use of ELECTROLUX assistent food processor. The crushed fish was freeze
dried (Hetosic, Heto Birkerød, Denmark), and the dried material was grinded
again by ELECTROLUX food processor to powder consistency. The fish powder
was mixed with casein, dextrin and basal mix and blended in the Crypto Peerless
EF 20 blender.
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Diet D The ethyl esters (Fri Flyt, Vesterålens Naturprodukter, Sortland, Nor-
way) used for diet D was kindly donated by Vesterålen Naturprodukter. The ethyl
esters were taken out of the capsules by syringe (Sabre 2.5 ml), and stored at
−10◦C until use. Ethyl esters were added at concentration 2.5 g/kg/day, and maiz
oil was added to reach a total fat content of 10 %. The oil was added as described
for diet A.
Diet E The fat source of diet E consisted of marine phospholipids (MPL-50Ca,
donated from EXIMO AS, Tromsø, Norway) added at a concentration of 2.5
g/kg/day, and maiz oil was added as a neutral fat source. The marine PL was
heated slowly in maiz oil to liquid consistency before it was added to the dry
material and blended as described for diet A.
Diet F Diet F consisted of soya lecitin (L-α-phosphatidylcholine, Sigma) as
sole lipid source. The soy lecitin was crushed in a mortar with dextrin. The
soy lecitin and dextrin mixture added to the other ingredients and blended in the
Crypto Peerless EF 20 blender.
Diet G Seal oil (Arctic Omega-3 Selolje) was used as sole lipid source in this
diet. The oil was added as described above in diet A.
Diet H The last diet contained cod-liver oil (Møller’s Tran, Oslo, Norway) as
sole lipid source. The oil is commercially available and was purchased at the
local supermarket (Rema 1000). The oil was added as soya oil in diet A.
2.3 Tissue Collection
Upon termination of the experiment, the animals were anesthetized intraperitoneal
with pentobarbital natrium (0.3 ml / 100 g). Loss of cornea and hind paw with-
drawal reflexes were used as indicators of deep anesthesia. When fully anes-
thetized, the rats were killed by cardiac puncture; the sternum was cut open and a
syringe was placed in the heart to collect the blood. Heart, liver, spleen, intestine,
brain, hippocampus and cerebellum taken out and snap frozen in liquid nitrogen.
The tissues were stored at−80◦C until further processing.
The blood was collected into centrifuge tubes containing EDTA as anticoag-
ulant, and immediately centrifuged at 3000 rpm and 4◦C for 10 min. The cen-
trifuged blood separated into 3 fractions; plasma on top, buffy coat(white blood
cells) in the middle, and red blood cells (RBC) at the bottom of the tube. Plasma
and RBC were separated for analysis, and stored at−80◦C until use.
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Table 2.4: Fatty acid composition of diets
Fatty acid Soy Salmon Cod EE MPL Soy lecitin Seal oil Cod liver oil
SFA
14 : 0 0.1 3.9 0.1 0.2 0.8 0.1 3.8 3.8
15 : 0 n.d 0.3 n.d n.d 0.1 n.d 0.2 0.3
16 : 0 10.6 13.2 10.6 9.1 8.3 8.3 6.0 9.0
17 : 0 n.d 0.3 n.d 0.3 0.2 0.1 0.1 0.7
18 : 0 3.1 2.5 2.0 2.2 1.2 1.7 0.8 1.9
20 : 0 0.5 0.2 0.4 0.4 0.2 0.1 n.d n.d
22 : 0 0.4 n.d 0.1 0.1 n.d 0.2 n.d n.d
24 : 0 0.2 n.d 0.2 0.1 n.d 0.1 n.d 0.1
MUFA
14 : 1n-9 n.d n.d n.d n.d n.d n.d 0.6 n.d
16 : 1n-9 n.d 0.3 n.d n.d 0.2 n.d 0.4 0.5
16 : 1n-7 n.d 5.4 0.2 0.4 1.3 0.1 13.9 6.3
18 : 1n-11 n.d n.d n.d n.d n.d n.d 3.6 1.5
18 : 1n-9 20.1 14.8 27.9 22.5 14.1 3.8 14.1 13.7
18 : 1n-7 1.4 2.5 0.7 0.8 0.8 0.6 3.7 3.3
20 : 1n-11 n.d 0.5 n.d n.d n.d n.d 2.0 1.3
20 : 1n-9 0.2 3.7 0.3 0.5 0.7 0.2 8.4 9.4
20 : 1n-7 n.d 0.2 n.d n.d n.d n.d 0.5 0.2
22 : 1n-11 n.d 3.9 n.d n.d 0.3 n.d 1.8 6.5
22 : 1n-9 n.d 0.4 n.d n.d n.d n.d 0.4 0.5
24 : 1n-9 n.d 0.5 n.d 0.2 0.1 n.d n.d 0.3
n-6
18 : 2n-6 51.0 4.6 49.9 37.8 22.1 25.1 1.7 1.6
20 : 2n-6 n.d 0.4 n.d n.d n.d n.d 0.2 0.2
20 : 3n-6 n.d 0.2 n.d n.d n.d n.d n.d n.d
20 : 4n-6 n.d 0.7 0.2 0.5 0.2 n.d 0.4 n.d
n-3
16 : 3n-3 n.d 0.3 n.d 0.1 n.d n.d 0.2 0.1
16 : 4n-3 0.2 0.4 n.d 0.1 n.d n.d 0.4 0.2
18 : 3n-3 5.4 1.1 1.1 1.1 0.6 3.2 0.5 0.9
18 : 4n-3 n.d 1.4 0.0 1.3 0.4 n.d 1.3 2.4
20 : 4n-3 n.d 1.6 n.d 0.2 n.d n.d 0.4 0.7
20 : 5n-3 n.d 6.9 0.4 9.6 4.4 0.1 6.4 7.9
22 : 5n-3 n.d 3.3 n.d 0.6 0.4 n.d 3.6 1.1
22 : 6n-3 n.d 11.0 1.2 6.6 5.4 n.d 7.5 12.2
∑ n-3 5.5 26.0 2.7 19.7 11.3 3.3 20.3 25.5
∑ n-6 51.0 6.0 50.1 38.4 22.3 25.1 2.2 1.8
n-3 / n-6 0.1 4.4 0.1 0.5 0.5 0.1 9.0 13.8
Results expressed as mg fatty acids/g sample. n.d: not detected. SFA: saturated fatty acid,
MUFA: monounsaturated fatty acid, EE: ethyl ester, MPL: marine phospholipid
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2.4 Lipid Analysis
Lipids occur in tissues in a variety of forms, and different extraction methods
may be necessary to extract lipids from different tissues. In this thesis the lipid
extraction of all tissues and diets was based on the procedure of Folch [88] using
chloroform/methanol (2 : 1 v/v) to a final volume 20 times the volume of the
tissue sample. Some adjustments were made to the extraction procedure for brain
tissue due to a problem with emulsion between the water and hexan phase when
extracting the lipids after transmethylation.
Brain Tissue Brain tissue was homogenized using a Ultra- Turrak T8 (IKA
Labortechnik). The homogenized tissue was kept at−80◦C until fatty acid analy-
sis. Total brain lipids were extracted by a modification of the Folch methode [88].
The tissues were first extracted in methanol and agitated at room temperature for
1 hour. Chloroform was added to a final volume of chloroform/methanol (2 : 1),
and the mixture was agitated for another hour at room temperature. The samples
were left at−20◦C overnight.
Red Blood Cells and Liver Lipids from RBC and the liver were extracted in
chloroforom/methanol (2 : 1), and stored at−20◦C overnight firstly to achieve a
maximum extraction, and secondly to avoid oxidation of the lipids.
2.4.1 Preparation of Fatty Acid Methyl Esters
The homogenate of brain, liver and RBC was filtered to remove tissue and pro-
tein remnants. The filtered chloroform/methanol solution was evaporated using a
Rotavapor with nitrogen supply (BUCHI B480), and ether was added to extract
the lipids. The lipid solution was evaporated to dryness under nitrogen, in a block
heater (Reacti-Therm) at 60◦C. The total lipid extracts were saponified with 0.5M
NaOH at 100◦C for 15 min, and transmethylated with 20 % BF3 at 100◦C for 20
min for brain tissue, and 5 min for RBC and liver [89]. The esters were extracted
from the solution by adding 2 ml hexan and 2 ml NaCl (0.9%) for brain tissue,
whereas RBC and liver were added 2 ml water instead of NaCl. The solution was
shaken for 15 sec, and centrifuged for 1 min at 3000 rpm, room temperatur. The
hexan phase was collected, and subsequently 2 ml of this solvent were added to
the lipid extract solution. The solution was shaken for 30 sec and centrifuged for
1 min at 3000 rpm, room temperatur. The hexan phase was collected and added
the previous 2 ml collected. The 4 ml hexan solution containing the lipids was
stored at−20◦C until gas chromatographic analysis.
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2.4.2 Gas Chromatographic Analysis
Methyl esters were analyzed using either Carlo Erva gas chromatograph (GC) or




220◦C), equipped with a 50m CP sil 88 (Chrompack) fused silica capillary column
(id: 0.32mm) [90]. The fatty acid composition was calculated using an integrator
(Turbochrom Navigator, Version 6.1), connected to the gas liquid chromatograph
(GLC) and a standard mixtures of methyl esters (Nu-Chek, Elyian, USA) The
absolute fatty acid composition was calculated quantitatively using 19 : 0 methyl
ester as internal standard.
2.5 Statistics
The software packages used for the statistical analysis were Statsoft. Inc (2004).
STATISTICA (data analysis software system). Version 6. www.statsoft.com, and
Statgraphics plus 5.1 (Statistical Graphics Corp). All results are expressed as
means± standard error of the mean (SEM). Calculation of mean, standard error,
and standard error of the mean, were performed in MicrosoftR©Excel 2002. An Q-
test was used to determine, and eliminate outliers, also by using MicrosoftR©Excel
2002.
Principal Component Analysis Principal component analysis (PCA) was ap-
plied to discriminate between the different dietary groups, using the full fatty acid
profile. When comparing the organs (brain, liver and RBC), PCA was perfomed
on the marine n-3 groups (salmon, ethyl ester, marine PL, seal oil and cod liver
oil).
Analysis of Variance Differences in food intake were tested using a one-way
analysis of variance (ANOVA). Significant differences between the dietary groups
for selected fatty acids were tested using one-way ANOVA. When theF-test was
significant, multiple comparisons among groups were measured using Tukey’s
HSD test (for groups with equal n), and unequalN-test (for groups with unequal
n). Significance level was set at p < 0.05.
Figure 2.1 shows the order in which the data were analyzed.
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Figure 2.1: Study design, statistical comparison of data. FA: Fatty acid, PCA: Principal compo-




Different diets were prepared containing different sources of n-3 and n-6 fatty
acids. The diets were analyzed by gas chromatography, and the full fatty acid
profil of all the diets is given in table 2.4.
3.1.1 Absolute Amounts of n-3 and n-6 in Diets
Table 3.1 shows the dietary amounts of marine n-3 FA, and two n-6 fatty acid. The
salmon and cod liver oil diets contained comparable amounts of marine n-3, the
ethyl ester and seal oil diets contained similar amounts of marine n-3, whereas the
marine PL together with the diets rich in n-6 FA contained less or no n-3 PUFA.
3.2 Food Intake and Weight Gain
There was no significant difference in food intake between the different dietary
groups. The average daily food intake and total weight gain during the experi-
mental period for the dietary groups are listed in table 3.2. The weight gain for
marine phospholipid (PL), soy lecitin and seal oil groups were significantly lower
than the salmon and cod groups, whereas the ethyl ester and cod liver oil groups
weight significantly less at the end of feeding than animals given the cod diet.
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Table 3.1: Amount of n-6 and marine n-3 fatty acids in diet.
Diet 18 : 2n-6 20 : 4n-6 18 : 3n-3 20 : 5n-3 22 : 5n-3 22 : 6n-3∑ marine n-3
Soy Oil 51 n.d 5.4 n.d n.d n.d n.d
Salmon 4.6 0.7 1.1 6.9 3.3 11.0 21.1
Cod 49.9 0.2 1.1 0.4 n.d 1.2 1.6
Ethyl ester 37.8 0.5 1.1 9.6 0.6 6.6 16.2
Marine PL 22.1 0.2 0.6 4.4 0.4 5.4 9.8
Soy lecitin 25.1 n.d 3.2 0.1 n.d n.d 0.1
Seal oil 1.7 0.4 0.5 6.4 3.6 7.5 17.5
Cod liver oil 1.6 n.d 0.9 7.9 1.1 12.5 21.5
Results expressed as mg. n.d: not detected. Marine n-3: 20 : 5n-3 + 22 : 5n-3 + 22 : 6n-3
Table 3.2: Daily food intake and weight gain
Daily Weight gain
Diet food intake after 3 weeks (g)
Soy Oil 42±2.0 88±5.1
Salmon 45±2.5 112±8.4
Cod 45±2.9 116±16.1
Ethyl ester 39±1.8 85±8.3a
Marine PL 42±1.4 80±8.1a,b
Soy lecitin 42±2.5 70±8.0a,b
Seal oil 37±1.9 71±8.4a,b
Cod liver oil 39±2.5 86±4.7a
Values represent means± SEM for 6 rats/group.
aSignificantly different from cod group, P<0.03
bSignificantly different from salmon group, P<0.01
3.2.1 Organs
Comparison of relative organ weight indicated that only the liver responded to the
diets. No differences were found in the weight of the brain between the different
dietary groups. The only significant difference in liver weight was found between
the marine PL group and soy lecitin group, where livers from animals fed marine
PL weight significantly more than those fed soy lecitin (p < 0.04). Fatty liver was
observed in animals in 5 of the dietary groups. In the cod group, 1 animal had
fatty liver, in ethyl ester group, 3 animals were found with fatty liver, in marine
PL group 2 animals had fatty liver, whereas the other 4 showed tendency towards
fatty liver. In the 2 groups recieving seal oil and cod liver oil, all the animals had
developed fatty livers.
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3.3 Full Fatty Acid Profil
The fatty acid profil of brain and liver tissues, together with red blood cells (RBC)
was analyzed by gas chromatography, and the resulting fatty acid compostitons
are given in table 3.3, 3.4 and 3.5, respectively. From these tables, it can be found
that diets rich in marine n-3 PUFA (salmon, ethyl ester, marine PL, seal oil and
cod liver oil) resulted in a considerably accumulation of the marine fatty acids;
EPA, DPA and DHA, in brain, in liver, and in RBC. The animals fed diets rich in
n-6 resulted in remarkably higher levels of LA and AA.
Table 3.3: Relative fatty acid composition in the brain
Fatty acid Soy Oil Salmon Cod EE MPL Soy lec Seal oil Cod liver oil
14 : 0 0.13±0.00 0.15±0.01 0.14±0.00 0.14±0.00 0.13±0.00 0.12±0.02 0.15±0.01 0.14±0.01
16 : 0 19.7±0.18 17.8±0.09 20.6±0.32 21.1±0.22 19.1±0.28 18.6±0.40 19.4±0.09 18.7±0.17
17 : 0 0.25±0.01 0.18±0.006 0.28±0.01 0.28±0.00 0.23±0.01 0.21±0.01 0.22±0.0 0.21±0.01
18 : 0 20.8±0.43 18.1±0.11 21.7±0.21 22.6±0.22 20.0±0.28 19.8±0.22 20.4±0.09 19.7±0.06
20 : 0 0.34±0.03 0.35±0.01 0.37±0.01 0.37±0.01 0.31±0.02 0.33±0.02 0.32±0.01 0.31±0.03
22 : 0 0.40±0.04 n.d 0.53±0.00 0.48±0.02 0.46±0.05 0.42±0.04 0.35±0.01 0.38±0.02
24 : 0 0.39±0.02 0.36±0.03 0.47±0.03 0.47±0.01 0.56±0.02 0.63±0.06 0.53±0.03 0.54±0.06
∑ SFA 42.0±0.66 36.9±0.19 44.0±0.49 45.5±0.43 40.8±0.57 40.0±0.54 41.4±0.14 39.9±0.14
16 : 1n-7 0.37±0.01 0.44±0.01 0.40±0.01 0.41±0.01 0.39±0.02 0.38±0.03 0.50±0.02 0.41±0.01
16 : 1n-9 0.13±0.00 0.13±0.003 0.14±0.0 0.14±0.00 0.13±0.01 0.06±0.03 0.13±0.01 0.12±0.00
18 : 1n-7 3.4±0.04 3.3±0.07 3.4±0.04 3.4±0.04 3.8±0.11 3.9±0.11 3.8±0.03 3.7±0.03
18 : 1n-9 17.9±0.23 17.9±0.10 18.1±0.11 18.8±0.05 18.1±0.38 17.5±0.52 19.1±0.11 18.9±0.21
20 : 1n-7 0.45±0.03 0.50±0.02 0.46±0.02 0.43±0.02 0.45±0.03 0.34±0.08 0.47±0.01 0.42±0.03
20 : 1n-9 1.6±0.07 1.5±0.06 1.6±0.07 1.6±0.04 1.5±0.0 1.6±0.07 1.5±0.03 1.6±0.04
22 : 1n-9 0.22±0.01 n.d 0.20±0.01 0.20±0.01 0.20±0.02 0.19±0.01 0.18±0.01 0.20±0.01
24 : 1n-9 n.d n.d n.d n.d 0.43±0.05 0.53±0.09 0.39±0.03 0.36±0.04
∑ MUFA 24.1±0.279 24.0±0.21 24.4±0.12 24.97±0.08 25.4±0.56 24.8±0.67 26.3±0.15 26.1±0.30
18 : 2n-6 0.88±0.02 0.48±0.02 0.89±0.03 0.89±0.02 0.86±0.01 0.80±0.03 0.32±0.02 0.35±0.02
20 : 3n-6 0.46±0.01 0.43±0.01 0.46±0.01 0.50±0.01 0.53±0.03 0.40±0.02 0.38±0.01 0.40±0.01
20 : 4n-6 9.7±0.12 8.6±0.06 9.3±0.05 8.5±0.08 8.7±0.1 9.3±0.22 8.6±0.07 8.1±0.05
∑ n-6 11.2±0.10 9.48±0.07 10.8±0.05 10.0±0.05 10.0±0.18 10.5±0.24 9.4±0.08 8.9±0.06
20 : 5n-3 n.d 0.24±0.01 n.d tr 0.10±0.04 n.d 0.18±0.01 0.23±0.02
22 : 5n-3 0.16±0.01 0.54±0.03 tr 0.35±0.01 0.38±0.03 n.d 0.43±0.03 0.47±0.01
22 : 6n-3 12.9±0.36 15.0±0.14 12.3±0.12 12.0±0.07 14.11±0.09 13.0±0.14 14.4±0.08 14.7±0.21
∑ n-3 13.0±0.36 15.8±0.15 12.3±0.12 12.4±0.06 14.6±0.10 13.0±0.14 15.1±0.10 15.3±0.15
n-3 / n-6 1.2±0.02 1.7±0.02 1.1±0.01 1.2±0.01 1.5±0.03 1.2±0.03 1.6±0.02 1.7±0.02
Results expressed as % of total fatty acids, mean± SEM, n= 5−6. EE: ethyl ester, MPL: marine phospholipid,
Soy lec: soy lecitin, SFA: saturated fatty acids, MUFA: monounsaturated fatty acids, n.d: not detected, tr: trace
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Table 3.4: Relative fatty acid composition in the liver
Fatty acid Soy Oil Salmon Cod EE MPL Soy lec Seal oil Cod liver oil
14 : 0 0.34±0.02 0.44±0.03 0.33±0.04 0.27±0.01 0.43±0.04 0.21±0.01 0.51±0.04 0.50±0.06
15 : 0 0.16±0.01 0.24±0.01 0.15±0.01 0.14±0.01 0.23±0.01 0.24±0.01 0.20±0.01 0.25±0.02
16 : 0 19.3±0.30 20.8±0.30 19.8±0.60 19.7±0.30 19.2±0.40 19.0±0.30 19.6±0.40 20.0±0.10
17 : 0 0.25±0.01 0.38±0.03 0.24±0.02 0.24±0.01 0.31±0.01 0.43±0.02 0.27±0.02 0.33±0.01
18 : 0 11.1±0.40 11.6±0.90 11.9±0.70 10.7±0.60 7.8±0.70 16.9±0.60 10.3±0.80 11.2±0.80
∑ SFA 32.1±0.96 33.4±0.98 32.4±0.26 31.1±0.98 28.0±0.53 36.8±0.28 30.9±1.06 32.2±0.79
16 : 1n-7 1.5±0.18 3.3±0.35 1.7±0.30 1.3±0.09 4.2±0.60 1.1±0.11 4.7±0.15 3.7±0.49
16 : 1n-9 0.26±0.03 0.24±0.01 0.25±0.02 0.31±0.03 0.43±0.03 0.06±0.04 0.30±0.01 0.33±0.03
18 : 1n-7 2.8±0.21 2.8±0.14 2.4±0.10 1.7±00.09 3.6±0.21 2.8±0.20 3.7±0.23 3.2±0.20
18 : 1n-9 10.1±0.71 12.1±0.53 11.2±0.85 10.7±0.45 16.2±0.77 5.1±0.47 13.1±0.66 13.7±0.48
20 : 1n-7 0.21±0.02 0.16±0.04 0.19±0.02 n.d 0.32±0.02 0.30±0.02 0.20±0.05 0.06±0.04
∑ MUFA 14.9±0.93 19.2±0.84 16.04±1.21 14.9±0.44 25.0±1.50 9.5±0.58 23.8±1.01 22.5±1.22
18 : 2n-6 26.0±1.41 9.4±0.46 24.1±0.66 23.8±0.68 20.9±0.63 20.8±0.74 8.10±0.86 7.47±0.75
20 : 3n-6 0.49±0.03 0.64±0.03 0.46±0.03 0.56±0.02 0.64±0.03 0.46±0.08 0.39±0.04 0.44±0.02
20 : 4n-6 16.7±0.54 8.07±0.37 16.9±1.09 10.2±0.66 6.4±0.68 23.6±0.90 7.3±0.54 6.6±0.53
∑ n-6 44.7±0.67 18.6±0.98 41.8±1.0 34.8±0.40 28.2±1.22 45.2±0.41 15.8±1.23 14.2±1.06
20 : 5n-3 0.50±0.05 7.8±0.36 0.76±0.08 5.8±0.45 4.8±0.23 0.45±0.02 8.5±0.49 9.4±0.79
22 : 5n-3 0.82±0.04 3.6±0.28 0.69±0.04 3.0±0.23 2.6±0.17 1.06±0.05 4.56±0.05 3.44±0.14
22 : 6n-3 3.8±0.32 15.3±0.65 6.5±0.38 10.6±0.51 9.7±0.43 4.3±0.08 14.7±0.66 15.8±0.36
∑ n-3 6.6±0.29 27.7±1.31 8.5±0.46 20.0±1.04 17.7±0.55 6.6±0.14 28.5±1.30 29.4±1.22
n-3 / n-6 0.15±0.01 1.5±0.14 0.20±0.01 0.58±0.04 0.64±0.03 0.15±0.004 1.9±0.22 2.2±0.24
Results expressed as % of total fatty acids, mean± SEM, n= 5−6. EE: ethyl ester, MPL: marine phospholipid,
Soy lec: soy lecitin, SFA: saturated fatty acids, MUFA: monounsaturated fatty acids, n.d: not detected.
3.4 Discrimination Between Diets
At the first level of comparison, the full fatty acid profile of all the diets were
analyzed by prinicpal component analysis (PCA) for brain, liver and RBC. The
PCA plots in figures 3.1,3.2, and 3.3 show patterns and correlations between the
diets and the brain, the liver and the RBC, respectively.
In all 3 organs, the diets rich in n-3 PUFA (salmon, seal oil and cod liver oil)
clearly separated from the diets rich in n-6 PUFA (soy oil, soy lecitin and cod),
whereas the diets containing high levels of both n-3 and n-6 FA (marine PL and
ethyl ester) did not show the same correlation pattern in all organs.
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Table 3.5: Relative fatty acid composition in the RBC
Fatty acid Soy Oil Salmon Cod EE MPL Soy lec Seal oil Cod liver oil
14 : 0 0.24±0.02 0.43±0.04 0.22±0.01 0.25±0.02 0.25±0.02 0.23±0.02 0.75±0.07 0.64±0.04
15 : 0 0.23±0.01 0.39±0.01 0.21±0.01 0.27±0.01 0.32±0.02 0.31±0.02 0.33±0.01 0.35±0.01
16 : 0 25.9±0.20 27.7±0.26 27.1±0.28 31.3±0.65 28.2±0.30 26.4±0.21 26.4±0.27 26.1±0.12
17 : 0 0.42±0.01 0.56±0.01 0.35±0.01 0.49±0.01 0.51±0.01 0.47±0.01 0.42±0.01 0.37±0.03
18 : 0 12.5±0.46 11.1±0.13 12.0±0.24 14.7±0.14 10.5±0.11 12.9±0.16 11.7±0.14 12.14±0.21
24 : 0 0.12±0.01 0.15±0.01 n.d n.d 0.17±0.08 0.06±0.04 0.17±0.04 0.15±0.03
∑ SFA 39.5±0.59 40.3±0.29 40.0±0.43 47.0±0.59 40.0±0.35 40.4±0.20 39.8±0.38 39.8±0.33
16 : 1n-7 0.45±0.05 1.2±0.10 0.57±0.08 0.48±0.05 0.85±0.10 0.49±0.03 1.7±0.13 1.2±0.13
16 : 1n-9 0.45±0.05 0.20±0.00 0.17±0.00 0.22±0.01 0.25±0.01 0.16±0.01 0.24±0.01 0.28±0.01
18 : 1n-7 2.9±0.08 3.1±0.05 2.8±0.07 3.0±0.06 3.3±0.12 2.6±0.06 3.9±0.07 3.6±0.12
18 : 1n-9 6.7±0.31 8.8±0.14 7.3±0.19 8.3±0.13 7.5±0.20 5.4±0.13 8.1±0.10 8.9±0.12
20 : 1n-9 0.13±0.01 0.45±0.01 0.06±0.04 n.d 0.20±0.01 n.d 0.82±0.04 0.94±0.02
∑ MUFA 10.6±0.45 13.9±0.24 11.1±0.30 12.5±0.19 12.3±0.37 8.6±0.17 16.0±0.28 16.3±0.19
18 : 2n-6 12.6±0.37 5.6±0.22 12.1±0.26 13.3±0.35 12.8±0.13 14.0±0.34 4.2±0.25 4.2±0.19
20 : 3n-6 0.49±0.02 0.52±0.01 0.58±0.03 0.55±0.02 0.56±0.02 0.44±0.02 0.38±0.01 0.37±0.01
20 : 4n-6 21.6±0.25 12.7±0.22 18.6±0.36 14.7±0.03 11.8±0.37 18.9±0.45 15.4±0.35 13.1±0.24
∑ n-6 35.0±0.40 19.1±0.37 31.7±0.32 26.9±0.28 25.4±0.49 33.7±0.27 20.1±0.57 17.8±0.43
18 : 3n-3 0.26±0.02 0.09±0.02 n.d n.d n.d 0.26±0.02 n.d n.d
20 : 5n-3 0.43±0.02 6.7±0.17 0.52±0.03 4.4±0.41 3.6±0.18 0.42±0.02 7.2±0.19 9.0±0.57
22 : 5n-3 1.9±0.04 3.1±0.07 1.6±0.04 3.3±0.07 2.4±0.2 2.1±0.04 3.2±0.06 2.9±0.11
22 : 6n-3 2.7±0.08 6.3±0.06 3.8±0.06 5.3±0.17 4.2±0.29 2.4±0.05 5.4±0.11 6.9±0.16
∑ n-3 5.3±0.09 16.5±0.20 7.7±0.48 11.7±0.52 11.5±0.47 6.3±0.14 15.9±0.27 18.8±0.68
n-3 / n-6 0.15±0.00 0.87±0.03 0.24±0.01 0.43±0.01 0.45±0.02 0.19±0.00 0.79±0.03 1.1±0.06
Results expressed as % of total fatty acids, mean± SEM, n= 5−6. EE: ethyl ester, MPL: marine phospholipid,
Soy lec: soy lecitin, SFA: saturated fatty acids, MUFA: monounsaturated fatty acids, n.d: not detected.
Brain
The PCA plot in figure 3.1 shows the discrimination between all of the diets in the
brain, based on the full fatty acid profil given in table 3.3. The animals recieving
marine n-3 PUFA was found separated from animals given vegetable diets. The
salmon group was found separated from the marine oil groups, whereas the ethyl
ester diet correlated with the n-6 rich diets. The soy lecitin diet did not correlate
to the n-6 diets and was found closer to the marine PL group in the interphase
between the n-3 rich diets and the n-6 rich diets. By the means of 3 components,
68.33% of the variability of the data was described.
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Figure 3.1: PCA plot of the brain, showing the discrimination of the full fatty acid profile in the
different dietary groups. The n-3 rich diets were separated from the n-6 rich diets. Marine PL was
situated in the interphase between n-3 and n-6 rich diets, whereas ethyl ester was clustered with
the n-6 rich diets. PC1, PC2 and PC3 explained 68.33 % of the data in the plot.
Liver
When PCA was applied to the full fatty acid profile (from table 3.4) of all the
dietary groups in the liver, the diets separeated into 4 main clusters. Figure 3.2
shows how the salmon, seal oil and cod liver oil diets correlated, and separated
from soy oil, soy lecitin and cod. The ethyl ester and marine PL diets were found
situated as 2 clusters in the interphase between the n-3 and n-6 clusters. 3 principal
components explained nearly 72.45 % of the variability in the data set.
Red Blood Cells
Figure 3.3 shows the discrimination of the full fatty acid profil (from table 3.5) for
the dietary groups in the RBC. The diets were arranged in 5 clusters. The groups
recieving diets rich in n-3 PUFA were found as 2 clusters, one formed by seal oil
and cod liver oil, and one formed by salmon. The groups given dites with high
content of n-6 FA highly correlated and were represented as one cluster. The ethyl
ester and marine PL diets were observed as 2 clusters in the interphase between
the n-3 and n-6 diets. The 3 principal components explained 71.38 % of the data.
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Figure 3.2: PCA plot of the liver showing the discrimination of the full fatty acid profile in the
different dietary groups. The groups fed diets rich in n-6 FA were found to the left of the plot,
the groups fed diets rich in n-3 PUFA were located to the right, whereas the diets rich in both n-3
and n-6 were situated in the middle. 72.45 % of the variability in the data were explained by 3
components (PC1, PC2 and PC3.)
3.5 Discrimination of Individual Fatty Acid Compo-
sition
EPA, DHA, and AA have distinct biological functions, accordingly, a major ob-
jective in this study was to determine whether the different diets containing marine
n-3 PUFA resulted in differences in the levels of each of these FA, in brain, liver
and RBC.
After finding particular patterns between the diets, one- way analysis of vari-
ance (ANOVA) was performed on selected FA, in order to establish differences in
the relative level of FA incorporated in the organs studied in this work. Conce-
quently, at the second level of comparison, ANOVA, was perfomed on the n-3 FA
ALA, EPA, DPA and DHA, and n-6 FA LA, DGLA and AA, for the salmon, ethyl
ester, marine PL, seal oil and cod liver oil groups.
3.5.1 Fatty Acid Comparison in the Brain
The ANOVA analysis of the n-3 and n-6 FA was conducted from the values in
table 3.3, for the TAG (salmon, seal oil and cod liver oil), ethyl ester and marine
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Figure 3.3: PCA plot of the RBC, showing the discrimination of the full fatty acid profile from
different dietary sources. The n-6 rich diets appeared as one cluster, separated from the n-3 rich
diets, clustered in 2 groups. Marine PL and ethyl ester were found as 2 clusters in the interphase
between the n-3 and n-6 diets. The 3 principal components explained 71.38 % of the data.
PL diets. The result from the ANOVA is summarized in table 3.6.
EPA was the only FA exclusively found in animals recieving long-chain n-3
PUFA. DPA was found in small amounts in the soy oil group as the only group
not recieving marine n-3 PUFA. DHA was found at high levels in all the groups,
however, the highest levels were found in animals who recieved marine n-3 diets.
TAG; Fish versus Oils
When comparing salmon with the marine oils (seal oil and cod liver oil), there
was no significant difference in the relative amount of the marine n-3, EPA, DPA
and DHA incorporated between these groups. The animals given salmon showed
significant higher levels of LA incorporated (p < 0.0 04), whereas the cod liver
oil diet had a significant lower level of AA than the salmon (p < 0.01) and seal oil
(p < 0.002). The cod liver oil diet resulted in a significant higher ratio of n-3 / n-6
than the seal oil diet (p < 0. 2).
TAG versus Ethyl Ester
Traces of EPA were found in the brain of animals recieving ethyl ester. These
animals showed significant lower level of DHA (p < 0.0 01), and DPA was sig-
nificant lower than the salmon (p < 0.001) and cod liver oil (p < 0.05) groups.
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Significantly more LA (p < 0.0001) and DGLA (p < 0.05) were found in the
brains of animals given ethyl ester than those given TAG diets, whereas AA levels
did not differ between the groups as to establish statistical differences. As for liver
and RBC, the n-3 / n-6 ratio in the brain was significantly lower in animals fed
ethyl ester as their source of n-3 (p < 0.0 01).
TAG versus Marine Phospholipids
EPA was found to be significantly lower in animals recieving marine PL than
those recieving salmon (p < 0.002) and cod liver oil (p < 0.002). DPA (p < 0.002)
and DHA (p < 0.0005) were significantly lower than the salmon group. How-
ever, DHA was significantly higher in marine PL compared to the ethyl ester (p <
0.003). LA was found at significant higher levels in the marine PL fed animals (p
< 0.0004), whereas the level of AA was similar to the TAG diets. The overall ratio
of n-3 / n-6 in the brains of rats fed marine PL differed significantly from rats fed
the TAG diets (p < 0.001).
Table 3.6: Summary of the relative n-3 and n-6 fatty acid composition in brain
Fatty acid Salmon EE MPL Seal oil Cod liver oil
18 : 2n-6 0.48±0.02a,b 0.89±0.02a,b,c 0.86±0.01a,b,c 0.32±0.02 0.35±0.02c
20 : 3n-6 0.43±0.01 0.50±0.01a,b,c 0.53±0.03 0.38±0.01 0.40±0.01
20 : 4n-6 8.6±0.06 8.5±0.08 8.7±0.13 8.6±0.07 8.1±0.05
20 : 5n-3 0.24±0.01 tr 0.10±0.04a,c 0.18±0.01 0.23±0.02
22 : 5n-3 0.54±0.03 0.35±0.01a,c 0.38±0.03a,c 0.43±0.03 0.47±0.01
22 : 6n-3 15.0±0.14 12.0±0.07a,b,c,e 14.11±0.09c,d 14.4±0.08 14.7±0.21
n-3 / n-6 1.7±0.02 1.2±0.01a,b,c,e 1.5±0.03a,b,c,e 1.6±0.02a,c,d 1.7±0.02
Results are expressed as % of total fatty acids. EE; ethyl ester, MPL; phospholipid, tr: trace.asignificantly
different from cod liver oil,bsignificantly different from seal oil,csignificantly different
from salmon.dsignificant from EE,esignificant from MPL. Significance level p < 0.05.
3.5.2 Fatty Acid Comparisons in the Liver
The ANOVA analysis of the selected FA in the liver was carried out on the relative
amounts of the FA given in table 3.4. Table 3.7 summarizes the differences found
between the different structural forms of n-3 (TAG, ethyl ester and marine PL)
administered throught the diets.
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TAG groups; Fish versus Oils
When comparing the n-3 FA in livers from the salmon, seal oil and cod liver oil
groups, no major differences were found between the diets. The only significant
difference was at the level of DPA, being significantly the highest in the seal oil
group (p < 0.05). Concerning the n-6 FA, the sole differences between the TAG
diets was the levels of DGLA, found to be significantly higher in the salmon diet
(p < 0.001). Animals fed cod liver oil showed the highest ratio of n-3 / n-6 within
the TAG diets, but the difference was not significant.
TAG versus Ethyl Ester
The animals recieving n-3 PUFA in the form of ethyl ester showed a significant
lower level of EPA and DHA in the liver, compared to the TAG diets (p < 0.01).
The levels of DPA in the ethyl ester group was only significant lower than the seal
oil group (p < 0.004), whereas the levels of LA and AA were significantly higher
than the TAG group (p < 0. 001 and p < 0.02 respectively). The total ratio of n-3
/ n-6 was significantly lower in the ethyl ester diet than the TAG diets (p < 0.008).
TAG versus Marine Phospholipids
The marine PL diet resulted in a significant lower level of EPA (p < 0.003), DPA
(p < 0.01), DHA (p < 0.001), whereas the levels of LA were significant higher
than the TAG diets. The animals fed the marine PL diet had a significant higher
level of LA (p < 0.0001). However, the phospholipid diet showed the lowest level
of AA in the liver, but the difference was not significant. The phospholipid diet
resulted in the lowest n-3 / n-6 ratio in the liver, being significant from the TAG
diets (p < 0.006).
3.5.3 Fatty Acid Comparisons in Red Blood Cells
The ANOVA analysis was performed on the n-3 and n-6 FA for the TAG, ethyl
ester and marine PL diets based on the values in table 3.5. Table 3.8 summarizes
the differences found between the fatty acids.
TAG; Fish versus Oils
The diet containing cod liver oil had significant higher levels of EPA incorporated
in RBC than the salmon (p < 0. 01) and seal oil diets (p < 0. 1). The cod liver oil
and salmon groups had significant higher levels of DHA than the seal oil group
(p < 0.02), whereas the seal oil diet lead to a significant higher level of DPA than
cod liver oil (p < 0.02). When considering the n-6 FA incorporated in the RBC
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Table 3.7: Summary of the relative n-3 and n-6 fatty acid composition in liver
Fatty acid Salmon EE MPL Seal oil Cod liver oil
18 : 2n-6 9.4±0.46 23.8±0.68a,b,c 20.9±0.63a,b,c 8.1±0.86 7.5±0.75
20 : 3n-6 0.64±0.03a,b 0.56±0.02 0.64±0.03 0.39±0.04 0.44±0.02
20 : 4n-6 8.1±0.37 10.2±0.66a,b,c 6.4±0.68e 7.3±0.54 6.6±0.53
18 : 3n-3 0.62±0.06 0.55±0.04 0.54±0.03 0.52±0.06 0.58±0.05
20 : 5n-3 7.8±0.36 5.8±0.45a,b,c 4.8±0.23a,b,c 8.5±0.49 9.4±0.79
22 : 5n-3 3.6±0.28 3.0±0.23b 2.6±0.17a,b,c 4.6±0.05a,c 3.4±0.14
22 : 6n-3 15.3±0.65 10.6±0.51a,b,c 9.7±0.43a,b,c 14.7±0.66 15.8±0.36
n-3 / n-6 1.5±0.14 0.58±0.04a,b,c 0.64±0.03a,b,c 1.9±0.22 2.2±0.24
Results are expressed as % of total fatty acids. EE; ethyl ester, MPL; phospholipid.as gnificantly
different from cod liver oil,bsignificantly different from seal oil,csignificantly different
from salmon,esignificant from MPL. Significance level p < 0.05.
from the diets, the salmon group had a significant higher level of LA than the oil
groups (p < 0.002). The n-3 / n-6 ratio, was significant higher in animals fed cod
liver oil than rats recieving salmon (p < 0.01) and seal oil (p < 0. 003).
TAG versus Ethyl Ester
The ethyl ester group showed significant lower levels of EPA than the TAG groups
(p < 0.003), whereas the level of DHA was significantly lower than rats fed salmon
(p < 0.02) and cod liver oil (p < 0.0003). Rats fed ethyl ester contained signifi-
cantly higher levels of LA (p < 0.0001) than TAG diets, significant higher levels
of DGLA compared to oil groups (p < 0. 001), and significant higher levels of
AA compared to salmon (p < 0. 04) and cod liver oil (p < 0.03). The n-3 / n-6
ratio was significant lower in the ethyl ester group compared to the TAG groups
(p < 0.0002).
TAG versus Marine Phospholipids
In RBC, the marine PL diet resulted in a significant lower level of EPA (p <
0.0001) and DHA (p < 0.0005), compared to TAG diets. DPA was significantly
lower in the marine PL group than salmon (p < 0.0 2) and seal oil (p < 0. 003).
The animals fed marine PL had a significantly higher level of LA incorporated
in their RBC (p < 0.0001), whereas the relative amount of DGLA was significant
higher than the oil groups (p < 0.0001). The level of AA was significant lower
in the marine PL diet than the oil groups (p < 0.04), and the n-3 / n-6 ratio was
significantly lower than the TAG diets (p < 0.0001).
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Table 3.8: Summary of the relative n-3 and n-6 fatty acid composition in RBC
Fatty acid Salmon EE MPL Seal oil Cod liver oil
18 : 2n-6 5.6±0.22a,b 13.3±0.35a,b,c 12.8±0.13a,b,c 4.2±0.25 4.19±0.19
20 : 3n-6 0.52±0.01 0.55±0.02a,b 0.56±0.02a,b 0.38±0.01 0.37±0.01
20 : 4n-6 12.7±0.22 14.7±0.03a,c 11.8±0.37a,b,e 15.4±0.35 13.1±0.24
18 : 3n-3 0.09±0.02 n.d n.d n.d n.d
20 : 5n-3 6.7±0.17 4.4±0.41a,b,c 3.6±0.18a,b,c,d 7.2±0.19 9.0±0.57b,c
22 : 5n-3 3.1±0.07 3.3±0.07a 2.4±0.21b,c,d 3.2±0.06a 2.9±0.11
22 : 6n-3 6.3±0.06 5.3±0.17a,c 4.2±0.29a,b,c,d 5.4±0.11a,c 6.9±0.16
n-3 / n-6 0.87±0.03 0.43±0.01a,b,c 0.45±0.02 0.79±0.03 1.07±0.06b,c
Results are expressed as % of total fatty acids. EE; ethyl ester, MPL; phospholipid.as gnificantly
different from cod liver oil,bsignificantly different from seal oil,csignificantly different
from salmon.dsignificant from EE,esignificant from MPL. Significance level p < 0.05.
3.5.4 Absolute Compositions of n-3 PUFA in Brain, Liver and
Red Blood Cells
In addition to the relative level of EPA, DPA, DHA, LA, DGLA and AA, the
absolute amounts of these FA were compared by one-way ANOVA, for all the
dietary groups.
Internal standard, used for quantitative measurements of FA, was mistakenly
not added to the salmon group in brain, and the cod liver group in liver and RBC,
hence, no absolute amounts are available for these groups.
Brain Due to very different amounts of EPA, DPA and DHA in the brain, the
graphic illustration of these FA was divided in two figures. Figure 3.4 shows
EPA and DPA, whereas figure 3.5 shows the amount of DHA incorporated in the
brain. EPA was only found at very low amounts in animals fed marine PL, seal
oil and cod liver oil. The amount of EPA was significantly lower in the marine
PL group than cod liver oil (p < 0. 002). DPA was found in significant lower
amounts in the soy oil and ethyl ester groups, whereas DPA in the ethyl ester
group was significantly lower than the oil groups (p < 0.004). Animals fed ethyl
ester, cod and soy oil had significant less amount of DHA in brains than animals
fed marine PL (p < 0.0001), seal (p < 0. 001) and cod liver oil (p < 0. 001),
and also soy lecitin (p < 0. 01). The animals fed cod liver oil had the highest
significant amount of DHA incorporated in the brain (p < 0.03).
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Figure 3.4: Absolute fatty acid composition (mg) of EPA and DPA in brain. Values are presented
as mean (n= 5−6) ± SEM. The concentration of EPA and DPA in the brain was very low. EPA
was only found in animals fed marine PL, seal oil and cod liver oil, however trace amounts were
detected in animals fed ethyl ester. DPA was found at slightly higher amounts, and only in animals
fed the diets rich in marine n-3, plus the soy oil group. The salmon group is not included in the
figure.* statistical significance from cod liver oil, ** statistical significance from all the groups, and
§ statistical significance from seal oil and cod liver oil. EE: ethyl ester, MPL: marine phospholipid.
Liver Figure 3.6 shows the actual amount of the marine n-3 FA incorporated in
the liver of the animals in the different dietary groups. The figure clearly shows
how groups recieving the marine n-3 rich diets (salmon, ethyl ester, marine PL,
and seal oil), contained significantly higher amounts of EPA (p < 0.00 1), DPA
(p < 0.0006) and DHA (p < 0.002) than those who were fed diets low (cod) or
depleted of marine n-3 (soy oil, soy lecitin). There was no significant difference
within TAG groups, or between TAG and ethyl ester regarding the amount of
EPA, DPA and DHA incorporated in liver. The amount of EPA in the marine
phospholipid group was significantly lower than seal oil (p < 0.02).
Red blood cells Figure 3.7 represent the quantititative amount of EPA, DPA
and DHA in RBC. The RBC contained very low amounts of these fatty acids. The
groups fed marine n-3 incorporated significant higher amounts of EPA, DPA and
DHA, than animals fed n-6 rich diets. Concerning EPA, the ethyl ester and marine
PL groups had significantly lower amount than the salmon (p < 0.0001) and seal
oil (p < 0.0001). DPA was significantly lower in the marine PL group than salmon
(p < 0.001), seal oil (p < 0.005) and ethyl ester (p < 0. 3). The salmon diet lead
to the highest level of DHA in RBC, significantly higher than the other diets (p <
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Figure 3.5: Absolute fatty acid composition (mg) of DHA in brain. Values are presented as mean
(n= 5−6)± SEM. The level of DHA in brain was fairly constant. Cod liver oil was found to give
the highest amount of DHA in the brain, closely followed by seal oil and marine PL. Animals
recieving cod and ethyl ester showed a reduction in the amount of DHA compared to soy oil and
soy lecitin.* and ** statistical significance from all the groups. The salmon group is not included
in the figure. EE: ethyl ester, MPL: marine phospholipid
Figure 3.6: Absolute fatty acid composition (mg) of EPA, DPA and DHA in liver. The values are
presented as mean (n= 5−6) ± SEM. Animals fed diets rich in marine n-3 (salmon, ethyl ester,
MPL and seal oil) showed an significant enrichment of EPA, DPA and DHA in the liver. The cod
liver oil group is not included in the figure. * statistical significance from the marine diets, **
statistical significance from seal oil. EE: ethyl ester, MPL: marine phospholipid
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0.003).
Figure 3.7: Absolute fatty acid compositio (mg) of marine n-3 PUFA in red blood cells. Values
are presented as mean (n= 5−6) ± SEM. The groups fed marine n-3 showed a higher incorpo-
ration of EPA in RBC. The values for DPA were low, and animals fed marine n-3 show higher
amounts of DPA then animals fed n-6 rich diets. DHA levels were highest in animals recieving the
marine diets, whereas the soy oil and soy lecitin contained the lowest amounts. The cod liver oil
group is not included in the figure. * statistical significance from the marine groups, ** statistical
significance from salmon and seal oil groups, and *** statistical significance from all the groups.
EE: ethyl ester, MPL: marine phospholipid
3.5.5 Absolute Composition of n-6 PUFA in Brain, Liver and
Red Blood Cells
The n-6 fatty acid arachidonic acid (AA) is present in most tissue, and is found in
high amounts in the brain. DGLA is the fatty acid prior to arachidonic acid in the
metabolic pathway of the n-6 fatty acids (see figure 1.5 for the metabolic pathway
of n-6 FA), and was therefore included.
Arachidonic acid Figure 3.8 presents the absolute amount of AA in the brain,
the liver and the RBC. In the liver, the animals fed marine n-3 showed reduced
amounts of AA. The greatest decrease was found for TAG and marine PL, whereas
ethyl ester did not reduce the amount to the same extent. In RBC, the diets rich in
n-6 contained the highest amount of AA. The brain contained the highest amount
of AA, and the soy lecitin group showed the highest amount of AA, whereas the
ethyl ester group had the lowest amount of AA.
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Figure 3.8: Absolute fatty acid composition (mg) of the n-6 fatty acid arachidonic acid (AA) in
the liver, the RBC and the brain. Values are presented as mean (n= 5−6)± SEM. In the liver, the
marine n-3 diets reduced the amount of AA compared to the n-6 rich diets. In RBC, the changes
in AA concentration were minor, however the n-6 rich diets resulted higher amounts than marine
n-3 diets. In brain, the highest level of AA was found in animals fed soy lecitin and the lowest in
animals fed ethyl ester. In this figure, the cod liver oil group is not included for liver and RBC,
and the salmon group is not included for brain. * statistical significance from soy oil, cod and soy
lecitin, ** statistical significance from marine and vegetal groups, § statistical significance from
soy oil,v statistical significance from all the groups. EE: ethyl ester, MPL: marine phospholipid
DGLA Figure 3.9 shows the amount of DGLA (20 : 3n-6) in the liver, the RBC
and the brain. In liver, the greatest concentration of DGLA was found in the
animals fed marine PL, whereas the lowest amount of this fatty acid was found
in livers of animals fed soy lecitin and seal oil. RBC contained extremely low
amounts of DGLA, and no major differences were observed between the groups.
In the brain, the amount of DGLA was found to be fairly constant between the
dietary groups. Nevertheless, the brains of animals recieving marine PL contained
the highest amount of DGLA.
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Figure 3.9: Absolute fatty acid composition (mg) of the n-6 fatty acid DGLA (20 : 3n-6) in liver,
RBC and brain. In liver and brain, the marine PL group and the seal oil group contained the highest
and lowest amount of DGLA respectively. RBC contained extremely low values of DGLA in their
cells. In this figure, the cod liver oil group is not included for liver and RBC, and the salmon group
is not included for brain. Values are presented as mean (n= 5−6)± SEM. * statistical significance
from all the groups. EE: ethyl ester, MPL: marine phospholipid
3.6 Organ Comparison (Brain, Liver and Red Blood
Cells)
At the last level of comparison, the dietary influence in the different organs was
studied by PCA analysis, regarding the diets containing marine n-3 FA (salmon,
ethyl ester, marine PL, seal oil and cod liver oil). The PCA was based on the rel-
ative levels of the FA. The PCA plot in figure 3.10 clearly shows how marine PL,
ethyl ester, and TAG (seal oil, cod liver oil and salmon) groups, highly correlated
in the brain, whereas the same is not true for liver or RBC. The brain as organ was
found separated from the liver and RBC. Liver and RBC were found separated in
2 groups, however the 2 clusters were more spread than the brain. The 3 principal
components explained 90.18 % of the variability in the data set.
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Figure 3.10: PCA plot showing the discrimination of the diets rich in marine n-3 PUFA (marine
PL, ethyl ester, salmon, seal oil and cod liver oil) in brain, liver and RBC. The diets influence the
organs differently. The brain separated from the liver and RBC, whereas the dietary groups did not
correlate to the same extent in liver and RBC. The 3 principal components explained 90.18 % of
the variability of data. MPL; marine phospholipid, EE: ethyl ester, TAG: seal oil, cod liver oil and
salmon, COD: cod liver oil, SEO: seal oil, SAL: salmon, BRA: brain, LIV: liver, RBC: red blood
cells.
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3.7 Summary of Results
3.7.1 PCA
Brain The diets rich in marine n-3 PUFA separated in 2 clusters, ethyl ester
correlated with cod and soy oil, whereas marine PL and soy lecitin were grouped
in the inter-phase between the n-3 rich and n-6 rich diets.
Liver and red blood cells Soy oil, soy lecitin and cod separated in one cluster.
Seal oil, cod liver oil and salmon also separated in one cluster, whereas ethyl ester
along with marine PL separated in 2 clusters in the inter-phase between the n-3
rich and n-6 rich diets
Organ comparison In brain, all the marine diets highly correlated. The marine
dietary groups were found more scattered in the liver, nevertheless as a cluster.
The marine diets showed higher correlation in the RBC than liver, however not to
the same extent as brain.
3.7.2 ANOVA
Fatty Acid Composition
Brain; relative amounts No differences were found within the TAG groups
concerning EPA, DPA and DHA. Ethyl ester diet resulted only in trace amounts
of EPA. DHA was considerably lower than in TAG groups, whereas n-6 FA were
higher. The marine PL group showed lower levels of EPA, however DPA and
DHA was only significant lower than salmon.
Brain; absolute amounts EPA was found in extremely low amounts only in
animals fed marine PL, seal oil and cod liver oil. DHA amounts were high in all
groups, however, cod and ethyl ester showed the lowest amounts, whereas marine
PL, seal oil and cod liver oil resulted in an enrichment of DHA.
Liver; relative amounts No differences within the TAG groups. The ethyl ester
and marine phospholipid diets resulted in lower levels of EPA, DPA and DHA, and
higher levels of LA.
Liver; absolute amounts Increased amounts of EPA, DPA and DHA were found
in animals fed marine diets. No difference was found between the various struc-
tural forms of n-3 PUFA (TAG, ethyl ester and marine PL). Marine diets greatly
reduced the amount of AA in the liver.
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Red blood cells; relative amounts Within the TAG groups, cod liver oil re-
sulted in the highest level of EPA, seal oil resulted in lowest DHA, and highest
DPA. Ethyl ester resulted in lower levels of EPA and DHA, and higher levels of
n-6 FA compared to TAG. Marine PL resulted in lower levels of EPA, DPA and
DHA, higher DGLA and lower AA levels than TAG diets.
Red blood cells; absolute amounts Animals fed n-3 PUFA showed the highest
amount of EPA, DPA and DHA. The TAG diets resulted in the highest amount of
EPA and DHA. The ethyl ester group showed to the highest amount of DPA. The
marine n-3 diets reduced the amount of AA in RBC.
4
Discussion
Polyunsaturated fatty acids (PUFA), especially DHA (22 : 6n-3), is present in high
amounts in the central nervous system (CNS) [29]. The n-3 FA are available in
the diet as 18 : 3n-3 (ALA) from vegetable origin, or as 20 : 5n-3 (EPA), 22 : 5n-3
(DPA) and 22 : 6n-3 (DHA) originating from marine sources.
Previous studies have established the possibility to affect the fatty acid profile
in brain, liver and red blood cells (RBC) through dietary manipulation [30, 37, 91]
and it has been shown that fish oil dramatically alters the PUFA composition of
brain and liver [92]. Ackman [93] pointed out that the molecular structure of
n-3 fatty acid ingested could have a profound effect on lipid production, and its
rate and total quantity absorbed. Hence, the physiological and pharmacological
properties of n-3 FA could be influenced by the molecular form in which they are
ingested.
The effects of dietary n-3 PUFA deficiency on nervous system function are
well documented, whereas those of a diet high in marine n-3 PUFA are less known
[45]. In this work, normal, healthy animals were fed diets rich, low or depleted
of marine n-3, in order to investigate the effect of dietary manipulation, and the
accretion of EPA and DHA in brain, liver and RBC. A number of studies have
investigated the effect of n-3 PUFA by using pure EPA and DHA fractions [40,
41, 94, 95, 96]. In this thesis, EPA and DHA from naturally available sources were
used in order to investigate the accumulation of these FA in rat tissues, following
48 CHAPTER4
a dietary intervention. The rate of incorporation of EPA and DHA in brain, liver
and RBC was investigated as a function of structure and amount of the dietary
lipids.
4.1 Animals
The animals used in this work were initially weighting 200 g. This weight cor-
respond to a rat in young adulthood of 7−8 weeks of age. When investigating
the incorporation of long-chain PUFA in the brain, the age of the animals must be
considered. Studies have shown that the adult brain appears to be more resistant
to changes in fatty acid composition [38], even when large amounts of dietary n-3
are administered [30, 92]. The developing brain, in contrast, seems to be more
plastic and susceptible to changes [27, 38].
Food intake and weight gain The average food intake during the 3 week ex-
perimental period did not differ significantly between the groups. Interestingly, as
seen in table 3.2, the weight gain show that animals fed the fish diets (salmon and
cod) gained significantly more weight than the other animals, apart from the ani-
mals in the soy group. According to table 2.3, all diets contained similar amounts
of fat, protein and energy, apart from the marine PL and ethyl ester diet, containing
less fat and energy, leaving the protein source the only major difference between
the diets. The fish diets contained fish protein, from the fish filets, in addition to
casein, which might have lead to a increased growth of the animals fed salmon
and cod. Others have found a similar increase in weight gain in animals fed fish
protein compared to milk protein (unpublished data).
Fatty liver Despite similar amounts of fat in the diet, some of the animals devel-
oped fatty liver (hepatic steatosis). It was especially animals recieving diets with
high content of marine n-3 (ethyl ester, seal oil and cod liver oil) that developed
or showed tendency toward fatty liver. Even animals in the marine PL group re-
cieving less dietary fat showed fatty liver. Fatty liver is an excessive accumulation
of fat in hepatocytes (liver cells). Although not a normal condition, fatty liver is
usually not harmful or causing damage to the animal. Eating fatty foods does not
by itself lead to fatty liver, however dietary components may influence liver in a
negative way [97]. Triacylglycerol (TAG) is synthesized in liver, and stored as fat
droplets or secreted into the blood as VLDL (very low density lipoprotein). Fatty
liver is believed to result from disturbance of the process of TAG synthesis i.e.,
decreased incoporation of TAG into functional VLDL, or of VLDL synthesis and
secretion i.e., impaired export of VLDL from hepatocytes [98].
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The fatty liver found in animals fed high amounts of n-3 PUFA may be a result
for a surplus of n-3 deposited in the liver, which can have a profound influence on
the liver fatty acid profile [91].
4.2 Preparation of Diets
One of the main challenges in this study were to prepare eight comparable diets.
This however, was not feasible, since two of the lipid sources (soy oil and soy
lecitin) did not contain long-chain n-3 PUFA (EPA, DPA or DHA), and one was
extremely poor in marine n-3 fatty acids (cod). The different sources of n-3 did
not only differ in the lipid structure, but also in the distribution of the marine n-3
FA within the various sources. Thus, the diets contained different amounts of the
marine n-3 FA EPA, DPA and DHA. When preparing the diets, there was another
element of consideration; to ensure 10 % fat in all diets, the differences in the
amount of n-3 sources added (see table 2.2) was compensated using maiz oil. Maiz
oil is a vegetal oil rich in n-6 FA, thereby introducing high amounts of 18 : 2n-6 to
some of the marine diets (cod, ethyl ester and marine PL). The extreme variation
in the amount of 18 : 2n-6 present in the diets will not be discussed further in this
thesis.
Analysis of the diets regarding protein, energy, fat, ash and dry matter, were
made after the termination of the feeding trial. The analysis showed that the ma-
rine PL diet and the soy lecitin diet contained less fat than the other diets (table
2.3). The analysis of the diets should therefore have been made in advance in
order to detect these mistakes, and new diets could have been prepared containing
the proper fat content.
4.2.1 Amount of Marine n-3 PUFA in the Diets
The amount of the different n-3 and n-6 FA varied considerably in the different
diets (table 3.1). The amount of 18 : 2n-6 was extremely high in soy and soy lecitin
diets, as well as for the diets receiving additional maiz oil supplement (cod, ethyl
ester and marine phospholipid). The salmon diet contained the highest amounts
of 18 : 2n-6 of the diets recieving the marine n-3 PUFA as sole fat source. This
can indicate that the salmon used in the experiment was a farm fish, fed a vegetal
diet.
As previously mentioned, the various n-3 diets differed in the amounts of EPA,
DPA and DHA, together with the total amount of marine n-3. The ethyl ester diet
contained the highest amount of EPA, the salmon and cod liver oil diets contained
the highest amounts of DHA, and the salmon and seal oil diets contained the
highest dietary amount of DPA. Salmon and cod liver oil contained comparable
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amounts of EPA, DHA, and total amount of marine n-3 FA (EPA+DPA+DHA).
Seal oil and ethyl ester diets contained similar amounts of total marine n-3 FA,
however the individual marine n-3 FA differed greatly. Of the diets rich in marine
n-3 FA, the marine PL diet containd the lowest amount of the individual marine
n-3 FA, and also the lowest amount of total marine n-3, explained by the low fat
content in this diet. Although the diets differed greatly in the amount of marine
n-3 FA, comparisons will be made regarding the incorporation of EPA and DHA
in the brain, the liver and the RBC for the diets rich in n-3 PUFA. Nevertheless,
the amount will also be considered.
4.2.2 Structure of n-3 PUFA
TAG Three groups were given n-3 PUFA in the form of TAG (salmon, seal oil
and cod liver oil). Seal oil and fish oil contain large amounts of preformed long-
chain n-3 FA located in different positions within the TAG molecule. In seal oil,
DHA is located mainly in thesn-1/3 position, whereas in salmon and cod liver oil,
DHA is mainly found in thesn-2 position of TAG. Different positioning of n-3
PUFA within the TAG molecule may affect the intestinal absorption, metabolism
and distribution of dietary n-3 PUFA [93, 99].
It has been demonstrated that lymphatic absorption of FA is enhanced when
the fatty acid is located in thesn-2 position in dietary TAG [100]. Studies have
shown that the intramolecular distribution of n-3 FA in dietary TAG affects both
the fatty acid distribution of TAG in chylmicrons [101], and the metabolism of
chylomicrons [102]. However, Jensent al. [103] found no effects of TAG struc-
ture of dietary fat in brain phospholipids when feeding rats either seal oil or fish
oil diets. Sommer-Hartvigsenet al. [37], on the other hand, showed that brain
phosphatidylethanolamine (PE) differed significantly from diet based on specific
structured TAG (18 : 3n-3 insn-2 position) compared to randomized TAG, indicat-
ing that the metabolism of fatty acid is related to their position within the dietary
TAG. Different tissue respond differently to the fatty acid positioning within the
TAG molecule, and the bioavailibilty of FA in thesn-2 position appears to be
higher in brain, whereas DHA equally distributed in TAG lead to in higher levels
of DHA in liver [104].
Ethyl ester Ethyl esters are relatively rare in natural foods, and it is therefore
natural to assume that the absorption and transport of FA presented as ethyl ester
are not identical to that of natural fats [99]. Early studies [105, 106] suggested that
n-3 FA as ethyl ester are absorbed differently and hydrolyzed to a lesser degree in
humans compared to TAG-EPA or free EPA. The difference is possibly the result
of poor hydrolysis of EPA ethyl ester by pancreatic lipase [105]. However, given
DISCUSSION 51
sufficient time, EPA as ethyl ester is found to be absorbed equally to TAG-EPA
[99]. Honget al. [94] and Frøylandet al [107] found in their studies, that EPA
and DHA in the form of ethyl ester did not mimic the physiological activity of fish
oil, at least in affecting hepatic fatty acid oxidation.
Phospholipid There are evidence indicating that LC PUFA as dietary phospho-
lipids (PL) are more efficiently incoporated than LCPUFA in the form of TAG.
The dietary supply of AA in the form phospholipid has shown to have clear ef-
fects on brain lipid composition [108, 109]. Wijendran [108], showed that in
baboon neonate brain, the accretion of AA provided as phospholipid was 2-fold
greater than as TAG. Lemaitre-Delaunayet al. [109], provided evidence for higher
bioavailability of DHA when provided as phospholipid compared to TAG for in-
corporation into erythrocytes in human adults. Further, preterm infants fed a for-
mula supplemented with n-3 and n-6 long-chain PUFA in the form of phospho-
lipids, at a significant lower concentration than human milk, developed similar
composition of LCPUFA in plasma and RBC as human milk-fed infants, sug-
gesting that the FA from the phospholipid source is more efficiently incorporated
[110].
4.2.3 Lipid Sources
The different lipid sources used in this experiment differed in the structures of
FA. All sources (apart from marine phospholipid and soy lecitin) were commer-
cially available. The various sources were to be compared concerning the rate of
incorporation of EPA and DHA, in rat tissue.
Soy oil The group recieving soy oil was chosen as a “reference” diet, and was
meant to reflect Western diets, being extremely rich in n-6 fatty acids, and low or
depleted of, long-chain n-3 PUFA. The lipid structure in the soy oil used was in
the form of triacylglycerol (TAG), and was a n-6 control to the marine n-3 TAG.
Soy oil contains 18 : 3n-3 and 18 : 2n-6, know as the precursors of long-chain
PUFA of the n-3 and n-6 families.
Fish oil, ethyl ester and seal oil The fish oil used in this experiment (Møllers
Tran) is one of the most common n-3 supplement in Norway. The capsules is to-
gether with fish oil traditionally the most common n-3 supplement in Norway. The
capsules used in this study (Fri Flyt, Vesterålen Naturprodukt) were chosen based
on the chemical structure of the n-3 PUFA, here available as ethyl esters. Seal oil
was included in the study for its similarities with fish oil, however differing in the
intramolecular structure of the TAG molecule. Seal oil is rapidly increasing as a
52 CHAPTER4
n-3 supplement in Norway. The seal oil used in this study (Arctic omega-3 seal
oil) is produced from the blubber of harp seal(Pagophilus groenlandicus), and
hence does not have the charactheristic adverse taste of fish oil, produced from
fish liver.
Marine phospholipids The marine phospholipids (Eximo AS) used in the ex-
periment are extracted from marine sources, and are extremely rich in PUFA of the
n-3 family. They are particularly rich in DHA and EPA, which constitute almost
50 % of the total FA in the ratio 2 : 1 (DHA : EPA).
Fish filets Two fish were also included in the experiment. One fatty fish (salmon)
and one lean fish (cod). Fat from salmon is available in the form of TAG, whereas
in cod, the fat excists in the form of phospolipids. It was not possible to compare
the 2 fish diets directly, due to very different amount of fat as previously men-
tioned in 2.2. However, the most interesting use of the fish diets was to compare
the fatty fish with the other n-3 supplements given either as oils, marine PL or
ethyl ester. This in order to investigate a “natural” occuring n-3 PUFA source, in
comparison to other marine n-3 supplements available, regarding the rate of incor-
poration of EPA and DHA in rat tissue. The lean fish diet gave clear indications
that cod is not a good n-3 source as salmon, or other marine n-3 supplements, for
increasing long-chain n-3 PUFA concentrations.
Soy lecitin The soy lecitin diet was added to match the marine PL treatment,
hence, it was a n-6 control for the n-3 PL. Soy lecitin from Sigma has high content
of FA in the form of phospholipids. Phosphatidylcholine (lecitin) is an emulifier,
used mainly as stabilizers of industrially prepared foods [111]. Soy lecitin prod-
ucts has no clear effects on the lipid profile beyond those attributable to its high
LA content [112].
4.3 Incorporation of Marine n-3 PUFA
When investigating the incorporation of EPA and DHA in the brain, the liver and
the RBC, both relative and absolute amounts were used. Unfortunalty, absolute
amounts are missing for the salmon group in brain, and cod liver oil group in
liver and RBC. Therefore, the relative amount was mainly used in this thesis,
nevertheless, the absolute amounts are also mentioned.
Differences between the relative and absolute amounts of FA were found for
FA incorporated in brain, liver and RBC. The relative amount of each FA is in-
fluenced by the amount of the other FA present in the tissue, thereby affecting
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the relative amount each other. The absolute amount of each fatty acid is the ac-
tual amount found in the tissue, and consequently gives a more correct view of the
amount incorporated. In this discussion, when referring to the level of a fatty acid,
the relative level is implied, whereas the amount indicates the absolute amount of
the fatty acid.
There was no control group in this experiments. The animals were considered
to be their own controls, and changes in the fatty acid profile in the tissues were
assumed to be a response of the dietary intervention. Since the soy oil and soy
lecitin diets did not contain long-chain PUFA of the n-3 family, the level of EPA,
DPA and DHA in these two groups was undertaken to represent the basal level of
these FA in brain, liver and RBC, and can be considered as a control groups [21].
Changes in the levels of EPA, DPA and DHA, must therefore be assumed to arise
from dietary manipulation.
Table 4.1 summarize the dietary amount of EPA, DPA and DHA, and the rate
of incorporation of these FA in the brain, the liver and the RBC.
Table 4.1: Rate of incorporation of EPA, DPA and DHA in brain, liver and RBC
Fatty acid Tissue Rate of incorporation (absolute amounts)
EPA
Diet∗ EE > cod liver oil > salmon > seal oil > MPL
Brain 1 Cod liver oil > seal oil > MPL > EE
Liver 2 Seal oil > salmon > EE > MPL
RBC2 salmon > seal oil > EE > MPL
DPA
Diet Seal oil > salmon > cod liver oil > MPL > EE
Brain cod liver oil > seal oil > MPL > EE
Liver Seal oil > EE > MPL > salmon
RBC Salmon > seal oil > EE > MPL
DHA
Diet Cod liver oil > salmon > seal oil > EE > MPL
Brain Cod liver oil > MPL > seal oil » EE
Liver Seal oil > MPL > EE > salmon
RBC Salmon > seal oil > EE > MPL
∗Amount in diet,1 No data for the salmon group,2 no data
for cod liver oil group. EE: ethyl ester, MPL: marine phospholipid.
4.3.1 Brain
The brain is a well-protected organ, regarding polyunsaturated fatty acids [48].
A restiction of n-3 fatty acid for a very short period causes few anomalies in the
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PUFA profile of the brain and its organelles [48], however, other organs i.e., liver
and plasma, respond rapidly to different amounts of n-3 FA in diets, and the PUFA
profile is highly affected by diet [30, 107].
Animals fed marine n-3 FA showed considerably higher relative levels of EPA
and DHA in the brain, whereas the differences between the different groups re-
garding absolute amounts were not as profound. EPA was only found in brains of
animals fed diets rich in marine n-3 FA, whereas DHA was found in high amounts
in all groups. Nevertheless, animals fed marine n-3 PUFA showed an enrichment
of DHA in the brain. There was no major difference in the level of saturated [91]
and monounsaturated fatty acids (20, 2 carbon) between the various diets, and
the monosaturated fatty acids was not affected by the diet. The level of 18 : 1n-9
was not affected by the diets, which presumably indicates that the myelination
of the nerve cells was not affected by the diets [30], since myelin contains high
levels of 18 : 1n-9 [113]. 18 : 2n-6 level was highest in the animals fed soy, soy
lecitin and cod, as well as the marine diets added maiz oil (ethyl ester and marine
PL), indicating that the brain takes up this fatty acid [37], which is not syntesized
by mammals. The level of DPA was increased in animals fed marine n-3 diets,
suggesting that this fatty acid is either taken up by the brain, or synthesized within
the brain [37].
The changes observed in the fatty acid profile of the brain reflects changes in
total brain phospholipids. The fatty acid changes occuring in the brain may differ
within the different types of phospholipids (PE, PI, PC∗), as it is expected that the
different phosphoplipid classes exhibit different rates of metabolism [114]. Alsted
and Høy [115] found that the fatty acid profiles of the phospholipid subclasses
were affected by dietary fats from marine source. The phospholipid subclasses
respond differently to dietary manipulation, and PC and PS significantly increased
the levels of DHA following fish oil feeding. Sommer-Hartvigsen and coworkers
[37] found DHA levels to be similar in the phospholipids in the brain from animals
fed different diets, however, the levels of DHA in brain PE differed significantly
between the different diets.
EPA EPA was not detected in diets with low (cod) or no (soy and soy lecitin)
marine n-3 FA, and was found only at trace amounts in the ethyl ester group.
This indicate that unless EPA is administered directly, no significant accumulation
occurs in the brain [115]. The content of EPA in brain was extremely low (ranging
from 0.04-0.09 mg), even in the groups recieving high amounts of marine n-3 FA.
This correspond well with other studies [30, 37], which have found low EPA and
DPA levels, although the animals were fed high amounts of fish oil.
The amount of EPA found in brain tissue in the different dietary groups, does
∗PE; phosphatidylethanolamine, PI; phosphatidylinositole and PC; phosphatidylserine
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not seem to correspond to the amount administered through the diets, as shown
in table 4.1. EPA amounts in cod liver oil, seal oil and marine PL groups seemed
to be incorporated in a dose dependent matter, and the results suggest that the
amount of EPA administered is more important than structural form, ans structural
positioning within TAG of fatty acid, regarding the incorporation of EPA in brain.
EPA in the form of ethyl ester on the other hand, did not incorporate in a dose-
dependent matter, and EPA in the form of ethyl ester resulted in the lowest amount,
although the dietary level was the highest. These results indicate that EPA is less
incorporated into the brain when administered as ethyl ester.
DHA The amount of DHA in the brain excessivly overcome the amount of EPA
and DPA, not surprisingly, since DHA is the most abundant fatty acid in the brain
[29], and EPA and DPA are only found at low levels [30]. The levels of DHA
remained relatively unaffected by ditary n-3 PUFA, indicating that DHA play an
important role in the brain [116, 117], and is not easily manipulated by dietay
means [118]. The result of Bourre and coworkers [118] suggests that brain DHA
is highly preserved or maintained in the brain, at the expense of other organs.
There was a small, but significant increase in the relative level of DHA in the
salmon, cod liver oil, seal oil and marine phospholipid groups compared to soy oil,
ethyl ester, cod and soy lecitin. No difference was found at the relative level of
DHA within the TAG groups. The absolute amount, however, showed that animals
fed cod liver oil had significant higher amounts of DHA incorporated in the brain,
than seal oil (no data for salmon). The significant increase of DHA in animals
fed cod liver oil was most presumably due to the highest dietary amount of DHA.
It is therefore reasonable to suggest that the incoporation of DHA in the brain is
independent of the positioning of FA whitin the TAG molecule, when sufficient
amounts of n-3 PUFA are available in the diet, as proposed by Christensen and
Høy [91]. The results presented indicate that the structural form in which the
FA are presented may play a role for the bioavailability of DHA to the brain. If
presented as marine phospholipid, even at lower concentrations than TAG, the
level of DHA increased to the same amount as seal oil fed animals. This suggests
that phospholipids are incorporated at a high rate in the brain, even at lower dietary
amounts [108]. Surprisingly, cod and ethyl ester seemed to reduce the level and
amount of DHA in the brain compared to soy oil and soy lecitin.
One explanation to the small changes in the level and amount of DHA in the
brain, may be the slow renewal of membranes in the brain [11]. 3 weeks of feeding
diets high in marine n-3 FA may not be sufficient period of time to change the
fatty acid profile in the brain to a great extent. Lim and Suzuki [96] suggested
that it takes a certain period of time after the intake of dietary DHA, for it to be
incorporated into the brain.
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4.3.2 Liver
The liver hepatocyte (liver cell), is the main site for the biosynthesis of 20- and
22-carbon PUFA from 18 carbon precursors, and the formation of lipoproteins
that transport fatty acids in the plasma. The liver production of PUFA is both for
synthesis of its own membrane PL and for export and uptake by most other cells
[10]. It is clear that the liver is able to desaturate ALA to DHA [83] and studies
have provided evidence that plasma DHA, which could be derived from synthesis
in liver or from diet, is taken up and esterified into brain lipids [25, 119].
Bourre and coworkers [30] showed that increasing amounts of dietary fish oil
resulted in a parallel increase in the levels of long-chain n-3 PUFA in the liver. In
the same study, it was showen that high dietary content of fish oil affected nearly
all fatty acid in the liver, and the liver function remained normal.
The liver is more susceptivle to influences by dietary FA than the brain [30,
91], and the dietary changes regarding EPA, DPA and DHA were more profound
than in brain. Animals recieving marine n-3 rich diets showed remarkably higher
amounts of EPA, DPA and DHA [94], than animals recieving diets rich in n-6.
EPA The levels of EPA in liver varied considerably between the animals fed
diets rich in marine n-3 FA and the animals fed n-6 rich diets, with an average of
7.2 % and 0.57 % respectively. The same was found for absolute amounts, being
significantly higher in animals fed marine n-3 compared to vegetal diets (3−4 mg
versus 0.2−0.4 mg, respectively).
Surprisingly, no significant difference was found between the amount of EPA
in liver of animals fed marine n-3 rich diets. The ethyl ester diet, containing the
highest dietary amount of EPA did not result in higher amounts of EPA incor-
porated. The rate of EPA found incorporated in liver did not correspond to the
dietary amount, indicating that the rate of EPA incoporated in the liver is affected
by the structure of the FA. The lower rate of incorporation of ethyl ester might
be a result of poor hydrolysis by pancreatic lipase compared to TAG, which is
highly hydrolysed by this enzyme [105]. The lower EPA amount might be a re-
sult of conversion of EPA to DPA, since DPA levels in liver and RBC of animals
fed ethyl ester corresponded to the DPA levels in animals fed higher amounts of
DPA. The conversion of EPA to DPA is known to occur, whereas further conver-
sion from DPA to DHA is highly restricted [80], due to the limiting step in DHA
formation occuring at the level of elongation of DPA to 24 : 5n-3 by a second∆6
desaturation [120]. The results might suggest that EPA in the form of ethyl ester
is more readily synthesized DPA than TAG-EPA and PL-EPA.
The TAG diets contained higher amounts of DHA than ethyl ester, and the
higher amount of EPA can be due to retroconversion of DHA to EPA. High levels
of DHA have shown to give retroconversion to EPA [107]. There was no dif-
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ference in the rate of incorporation between the structural positioning within the
TAG molecule, suggesting that the structural positioning within TAG is not of
importance when sufficient amounts of EPA are present in the diet.
These results indicate that the incorportation of EPA in liver is affected by
the structural form of EPA administered, and that ethyl ester-EPA is either less
effective than TAG and marine PL at increasing EPA levels in liver, corresponding
well with other studies [105, 106], or has a higher degree of conversion to DPA.
DHA As for EPA, the levels of DHA was excessivly higher in animals fed diets
rich in marine n-3 FA compared to animals fed diets rich in n-6 FA. The animals
fed the TAG diets contained the highest level, followed by ethyl ester and marine
PL, whereas the amount incorporated did not differ between the groups. The seal
oil diet contained considerably lower amount of DHA compared to the salmon
and cod liver oil diets, however the absolute amount of DHA incorporated in the
liver did not differ significantly between these animals. This might be a result
of the differences in the moleculare positioning in the TAG molecule, although,
Christensen [91] found no major differences related to TAG structure regarding
DHA in liver.
The amount of DHA found in the liver did not differ between the differ-
erent structural forms introduced, even though the dietary amount differed greatly.
These results indicate that the liver respond to the structural form of DHA pre-
sented in the diets.
4.3.3 Red Blood Cells
The fatty acid composition of the diet has been shown to have a major impact on
the fatty acid profile in plasma lipid, platelets and RBC. Vidgren and coworkers
[121] showed that fish diet and fish oil supplement increased the proportions of
n-3 FA in the membrane of RBC.
The erythrocytes contained very low amounts of EPA, DPA and DHA. EPA
levels were most affected by the diets, whereas the dietary changes in the levels
of DPA and DHA were only minor. EPA, DPA and DHA was considerably higher
in animals fed diets rich in marine n-3 FA compared to animals fed diets rich in
n-6 FA.
EPA Animals fed diets diets with low or no marine n-3 (cod, soy and soy
lecitin), contained extremely low amounts of EPA. As for the liver, ethyl ester,
even at the highest dietary level of EPA, resulted in significantly lower levels in-
corporated in RBC compared to TAG diets. It does not seems to be any relation-
ship between the dietary dose of EPA administered in the diet and the amount of
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EPA found in the RBC. This suggests that the differences in the level of EPA in
RBC is caused by the structure of the fatty acid rather than the amount.
DHA The amount of DHA incorporated in RBC appears to be dose dependent.
The diets with the highest amount of DHA showed the highest levels of DHA in
the RBC. The molecular structure of the TAG molecule does not seem to matter for
the incorporation of DHA into RBC. Surprisingly, the amount of DHA in animals
fed cod was similar to the marine PL, even though the amount in the diet was
considerably lower. It must, however, be noted, that the increase in the cod, ethyl
ester and marine PL diets compared the basal level of the soy oil and soy lecitin
groups, is not more than about 0.01 mg. It is difficult to draw any conclusions
regarding the rate of incorporation of DHA based on the low amounts present in
RBC.
4.3.4 n-6 Fatty Acids
The conversion of linoleic acid (LA) to arachidonic acid (AA) appears to be highly
regulated. Dietary LA poorly correlate with the AA content in tissues [19], and
the level of this fatty acid is not dramatically affected by diets [21].
It has long been know that increasing dietary levels of n-3 PUFA progressively
decreases the AA content of tissue phospholipids [96, 115]. Marine n-3 PUFA are
more effective than vegetal n-3 FA in altering the FA compostition of tissue PL
[19], and the antagonistic effect of EPA to AA and its metabolism are most likely
explained by the structural similarities between AA and EPA.
In this study diets containing high levels of marine n-3 LCPUFA affected the
levels of AA and DGLA, as found by others [37, 38, 70, 96, 122]. The TAG,
marine PL and ethyl ester groups showed decreasing levels of AA in liver and
RBC, but not in brain, compared to soy oil, soy lecitin and cod. The amounts of
AA in brain did not respond highly to the diets presented. Interestingly, marine
PL lowered the levels of AA in liver and RBC, but not in brain, whereas ethyl
ester fed animals showed great decreased brain levels of AA. The reduction in
AA amounts might result from decreased∆6 desaturase activity mediating LA
conversion to AA, which has been shown to be reduced in rats fed dietary fish oil
[123], or by increasing competition from n-3 FA for the desaturase and elonga-
tion enzymes needed for the convertion of LA to AA [81]. The decrease in AA
was accompanied by an increase in DGLA in salmon, ethyl ester and marine PL
groups. These result might suggest an inhibition of the conversion of 20 : 3n-6 to
20 : 4n-6 by∆5 desaturase [37, 104], or an increased synthesis of LA, being the
highest in these diets. However, brain levels of AA were unchanged in all diets,
although slightly lower in the marine n-3 diets than the n-6 diets.
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Excess dietary LA leads to a specific accumulation of DPA n-6 [20]. The lev-
els of DPA n-6 have been shown to be inversely related to the proportion of DHA,
and several studies report that increasing levels of DHA are followed by decreas-
ing levels of DPA n-6 [21, 22, 27, 37, 122]. These studies suggest that DHA
might be an inhibitior of DPA n-6 synthesis or, alternatively, a better sbustrate for
reacylation of the phospholipids. DPA n-6 was not investigated in this thesis, but
should be included in further studies.
4.4 Organ Comparison
The natural levels of EPA and DHA vary considerably between the brain, the liver
and the RBC of rats. EPA was not detected in the brains of animals not recieving
marine n-3 FA, and was found in extremely low amount (0.01 mg) in RBC of
animals fed diets depleted of marine n-3. The highest basal level of EPA and
DHA were found in the liver (0.2 mg) and brain (5 mg) respectively, whereas the
RBC contained the lowest basal level of DHA (0.05 mg). The different amount
of these FA indicate that EPA and DHA play different roles in the body, and are
therefore affected differently by dietary means [22, 42].
The diets rich in marine n-3 PUFA (salmon, ethyl ester, marine PL, seal oil
and cod liver oil) affected brain, liver and RBC in different manners. As shown
by PCA the marine n-3 diets highly correlated in the brain, indicating that the
marine diets not differed considerably regarding the incorporation of EPA and
DHA. The dietary influence varied more in the liver, suggesting that the liver
respond differently the to diets rich in marine n-3 FA introduced in this experiment
than the brain. The RBC showed similar dietary response as the liver, however the
diets seemed to correlate more. These results indicate that the various diets result
in different response in different tissue, and that individual tissues process PUFA
in different ways [10, 22].
The tissues vary in their response to the structural differences of the n-3 PUFA
administered. In the brain and liver, the marine PL increased DHA levels to the
same extent as the TAG diets, even at considerably lower levels in the diet, sug-
gesting that is is a good structural form for increasing DHA levels in brain. The
same is not true for the RBC, where the marine PL diet resulted in significant
lower amounts of EPA and DHA. The tissues investigated also differed in their re-
spons to the differences within the TAG molecule. In liver, the seal oil diet resulted
in similar amount of DHA incorporated compared to salmon, even at considerably
lower dietary level, indicating that the positioning of the FA in the TAG structure
affect the bioavailability, whereas the same was not found for the brain and the
RBC where the incorporation of TAG appears to be dose dependent. Liver and
RBC respond highly to the dietary changes introduces during the 3 week feeding
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period, whereas for the brain, 3 weeks did not seem sufficient to introduce major
changes in DHA levels.
The different dietary responses by different tissues highlight the importance of
examining more than just neural tissues in experiments that undertake dietary ma-
nipulation [22]. The physioloical effects induces by dietary marine n-3 in different
tissues may influence or affect the response in other tissues.
The diets rich in 18 : 3n-3 (soy and soy lecitin) did not show high levels of n-3
long-chain PUFA in the brain, the liver, or the RBC indicating that the conversion
of 18 : 3n-3 to its longer chain metabolites (EPA and DHA) is low in rat, and
that 18 : 3n-3 is not as effective as direct intake of EPA and DHA in increasing
the level of EPA and DHA in rat [22, 124]. Unfortunatly, there is no real control
group to compare the amount of EPA and DHA in the soy and soy lecitin groups.
Therefore, it is not possible to say whether or not the levels of EPA and DHA are
increased in animals fed soy and soy lecitin compared to a ordinary rat chow diet.
4.5 PUFA and the Brain
Brain EPA and DHA must be obtained either by uptake and further desaturation
and elongation of 18 : 3n-3, by other intermediary metabolites, or by uptake of
DHA itself from plasma[120]. It has been demonstrated that it is the brain as-
trocytes that are capable of forming DHA [125], and it has been suggested that
astrocytes may be important in supplying DHA to other brain cells.
The brain is able to synthesize DHA from 18 : 3n-3 [126], however, the major-
ity of the accumulating DHA seems to be synthesized in the liver [25] if 18 : 3n-3
is the main source of n-3 PUFA, and transported, possibly by chylomicrons [127],
to the brain. If dietary DHA is available, this can probably be transported to the
brain either in chylomicrons or in VLDL [91]. Innis and coworkers [120] suggest
that the synthesis of DHA from n-3 FA precursors is not the major route through
which developing brain accumulates high concentrations of DHA.
It has been shown that a modification in the dietary fatty acid profile affects the
fatty acid profile of cellular membranes and thereby the property of the membrane
components, receptors and enzymes. Dietary changes may therefore be of conse-
quence for cognitive functions such as learning and memory [37]. These effects
on cognitive performance have mostly been demonstarted in animals deficient in
n-3 FA, which exhibit impaired learning ability [28].
Studies have shown that DHA or fish oil (rich in both EPA and DHA) en-
hanced spatial memory or other types of memory in normal and aged animals
[45, 103]. However, the durations of the exposure to these diets were over two of
four generations, or, alternatively, following high n-3 FA concentrations.
The brain fatty acids are more susceptible to dietary influence at an early stage
DISCUSSION 61
of development than when fully developed. [27, 27, 37, 38, 39]. Several studies
have shown that an early supply of n-3 PUFA is able to affect brain function and
that the reversibility of changes should be dependent on the developmental stage
during which the deficiency occurs [39]. Moriguchi and Salem [27] explored
the issue of reversibility of losses in spatial task performance associated with n-3
PUFA deficiency in relation to the stage of development. Animals were rendered
deficient of brain DHA by deprivation of n-3 dietary fats through 3 generations.
Their findings gave indications that the performance in spatial tasks are closely
related to the level of brain DHA. When the rats were switched to an n-3 adequate
diet at birth, performance on the spatial learning and memory task was very similar
to the control group (adequate n-3 diet). When the rats were switched to n-3
adequate diet at weaning, the brain had substantially recovered after 6 or 10 weeks,
and performance was significantly different from the n-3 deficient group. The
young adult group were switched to the n-3 adequate diet at 7 weeks of age. After
6 weeks of diet repletion, nearly full recovery had occurred in the probe trial and
partial recovery for the spatial learning task. These findings are important as they
show that brain function can recover from a severe and extended n-3 fatty acid
deficiency in the nearly fully developed brain. Thus, juveniles and young adults
depleted of adequate n-3 fatty acid sources in early develpment, may be expected
to regain brain DHA and improve at least some aspects of brain function once
adequate sources of dietary DHA are provided.
However, in most studies, the exact time when changes in the fatty acid com-
position occured, after supplementation began, is rarely investigated. Another
factor to consider in comparing the time course required to change brain fatty acid
profil is the concentration of supplement being used, ranging from 5 to 20% of the
diet [128]. Improved learning resulting from high intake of DHA may be associ-
ated with greater membrane fluidity. Synaptic membranes in mice fed DHA-rich
diet have been reported to be more fluid than in control mice [129].
4.5.1 PUFA Deficiency
Effects of fatty acid composition on brain performance have mostly been demon-
strated with animals deficient in n-3 PUFA. Animal models of n-3 FA deficiency
can be used to help define the nature and extent of the functional deficits in the
nervous system that are associated with low or no intake of n-3 PUFA [28]. By in-
ducing n-3 deficiency, the variable to be studied may be magnified and behavioral
consequences may be more easily discerned.
A deficiency of dietary n-3 FA will not cause anomalies in the brain unless ex-
tremely prolonged, i.e., over several generations. By feeding rats diets depleted of
n-3 FA, the brain cells and intracellular organelles will conserve a normal quantity
of total quantity of PUFA, however the various cell types and organelles show a
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consistent decrease in DHA, that will be compensated for by an increase in DPA
n-6 [11, 21, 42, 48].
Nonhuman primates deprived of dietary n-3 FA during gestation and infancy
show depletion of n-3 PUFA from plasma lipids, and this depletion is associated
with a significnat impairment in the development of visual acuity [26]. Several
previous studies have reported that n-3 fatty acid deficiency can impair spatial
learning ability [11, 21, 130] and memory, which can be reversed by a diet rich in
marine n-3 [27, 41].
Results have shown that nervous system DHA can be restores, although slowly,
after dietary depletion of n-3 FA during development [46, 48]. However, these
studies used 18 : 3n-3 as the n-3 source, and the synthesis of this fatty acid to
long-chain PUFA is know to be slow [80]. Although DHA levels can be restored,
there are indications that the functional effects of the DHA decline may not be re-
versible. Juvenile n-3 deficient rhesus monkeys repleted DHA levels when fed fish
oil rich in DHA [47], however the electroretinographic changes observed during
n-3 deficiency persisted [4]. Early n-3 PUFA deficiency, regardless of subsequent
supply, resulted in hypertension in rats [6]. These studies demonstrate that the du-
ration of the n-3 deficient feeding and therefore the age at which repletion begins,
along with the length of repletion can be important variables [27]. The differences
in behavioral performance found between n-3 deficient and control animals might
reflect irreversible structural damage to the brain induced by the periode of n-3
deficiency in early development [27]. This is supported by observations that adult
rat brain hippocampal neurons [131, 132], as well as those in other brain areas
[132] are smaller after DHA deficiency.
4.6 Marine n-3 versus Plant n-3
α-linolenic acid (ALA, 18 : 3n-3) is found in vegetable oils, such as flaxseed oil
(45− 50 %), rapseed oil (10 %) and soy oil (7− 10 %). If ALA can be fully
syntesized to EPA and DHA in the human body, one could expect the same health
benefits from 18 : 3n-3 rich vegetable oil as direct intake of marine oil [7]. This
has not yet been demonstrated, and there is little evidence that the consumption of
vegetable oils rich in linolenic acid will have the same beneficial effect in prevent-
ing or treating chronic diseases such coronary heart disease. A study by Finnigan
and coworkers showed that ALA, and EPA and DHA have different physiological
effects [133].
In a study by Sanders and Roshanai [134], long-chain PUFA increased markedly
in platelets after supplementation with marine oil, whereas flaxseed oil failed to
show the same effect. The flaxseed oil gave only a modest increase in platelet
EPA, and DHA was not modified. This confirms that ALA is not readily con-
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verted to EPA and still less so to DHA [22, 26], in addition to being less effective
in increasing n-3 long-chain PUFA than a direct intake of these FA [133, 134].
Bourre and Dumont [124] showed that dietary porcine brain phospholipids
(rich in long-chain PUFA) are much more efficient than soybean phospholipids
(rich in 18 : 3n-3) for ensuring a normal level of DHA in tissues and brain sub-
cellular fractions. The study revealed that by giving the same amount of n-3 FA
in the diet, lower tissue levels of DHA were observed when soybean PL were
used compared to brain PL. The study concluded that dietary porcine brain PL
is a better source than soybean PL for attaining normal levels of DHA in tissues
and subcellular fractions. This is in accordance with other studies [22, 103, 115]
showing that long-chain PUFA are not readily made from 18-carbon precursors.
Numerous studies have compared fatty acid profile in vegans and omnivores
[135, 136], and showed that EPA and DHA levels were lower in vegans than in
omnivores†, as well at the ratio of n-3 / n-6 FA. In a study by Agrent al. [135],
the fatty acid profile of subjects eating a strict uncooked vegan diet for years was
compared to ominvore controls. In vegetarians, a prolonged consumption of high
levels of ALA resulted in very low levels of n-3 PUFA in RBC, platelets and serum
lipids.
Intake of fish oil, or other marine sources rich in EPA and DHA, is accompa-
nied by elevated levels of DHA in all tissue phospholipids, including brain lipids
[115], suggesting that preformed long-chain PUFA are more readily incorporated
and therefore better to secure optimal brain function than vegetal sources rich in
ALA.
In summary, I found that by feeding diets rich in marine n-3 long-chain PUFA,
higher levels of these were found in the brain, the liver and the RBC of rats.
The liver and RBC responded rapidly to the increased marine n-3 FA, whereas
the brain fatty acid profil was less susceptible to dietary changes, also shown by
Abedin and coworkes [22].
The tissues investigated in this work responded differently to the different
sources of long-chain n-3 PUFA introduced, and caution must be therefore be
made when suggesting that RBC levels of n-3 long-chain PUFA reflect brain levels
of these FA. In brain and RBC, EPA amounts seem to respond in a dose-dependent
matter, apart from the ethyl ester group, whereas the amount of DHA in brain and
liver seems to correlate with the structural form of FA introduced in the diets.
EPA in the form of ethyl esters appeared to be less incorporated than TAG-
EPA and PL-EPA in all organs studied in this work, and especially in the brain.
†Omnivore are animals/humans that consume both plants and animals.
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The lower incorporation rate of ethyl esters might result from a lower hydrolyses
by pancreatic lipase, hence, their absoption is slower when fed in this form [105,
106]. n-3 PUFA presented as marine PL seems to be a good structural form for
increasing levels of EPA and DHA, especially in the brain. Therefore, the industry,
when making n-3 supplements containing long-chain n-3 PUFA, should consider
the form in which the FA are presented.
4.7 Statistical Considerations
The pyramide in figure 2.1 represents the order in which the data were analyzed.
The large data set from tables 3.3, 3.4 and 3.5 made it necessary to apply principal
component analysis (PCA) in order to get a general idea of correlation patterns
and responses in the organs investigated, before starting the ANOVA analysis.
The PCA plots in figure 3.1, 3.2 and 3.3 show how the diets rich in long-chain n-3
PUFA clearly separated from the diets rich in n-6 FA, in all organs investigated.
Thus, PCA was a good statistical approach to structure the huge data set generated
from the experiments in this work.
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Conclusions
The aim of this thesis was to investigate different structural forms of marine n-3
FA introduced in diets, and the incorporation in the brain. Liver and RBC were
included, in order to observe the relationship between the rate of incorporation in
these organs.
• Liver and RBC fatty acid compostition are more susecptible to dietary FA
than the brain, and can be easily manipulated by dietary means during a 3
week feeding period. The rapid increase of n-3 PUFA in liver and RBC
levels compared to brain, suggests that it takes a longer period of time after
intake of n-3 PUFA for EPA and DHA to be incorporated into the brain.
Thus, a longer feeding period is probably needed to markedly change the
fatty acid compostition in the brain.
• The structural form of the marine n-3 FA introduced affects the bioavailabil-
ity for EPA and DHA in the liver and brain. The RBC appears to respond to
the dietary FA in a dose dependent matter.
• Dietary DHA introduced in the form of marine phospholipid appears to be
an efficient source for increasing the level and amount of DHA in the brain.
Further investigations are needed to confirm this result.
• Ethyl ester does not seem to be an efficient form for increasing EPA and
DHA levels in the brain, the liver and the RBC compared to TAG and ma-
rine PL. However, further investigation is needed in order to establish if
the reduction of DHA found in brain is actually caused by the ethyl ester
introduced, or an analytical mistake. Feeding animals ethyl ester over a
longer time period may aslo be necessary, as it appears that ethyl esters are
incoporated at a slower rate than TAG.
• The positioning of the marine n-3 FA within the TAG molecule seems to
affect the bioavailability of EPA and DHA in liver and brain. The seal oil
diet contained less marine n-3 than salmon and cod liver oil, nevertheless,
the level of EPA and DHA incorporated in liver and brain did not differ
significantly between the 3 TAG groups.
• There were differences the relative levels versus absolute amount incorpo-
rated for some of the FA investigated. Hence, the relative results do not
entirely correspond with the absolute amounts.
• Marine n-3 PUFA are more effective in increasing tissue levels of EPA and
DHA, than their 18-carbon precursor (ALA).
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The overall significance of this study is that different structural forms of n-3
FA seem to incorporate differently in the brain, the liver and the RBC. Marine
phospholipid, together with salmon, seal oil and cod liver oil, are good sources
for increasing n-3 PUFA levels, whereas the incorporation of EPA and DHA in




3 weeks do not seem to be sufficient amount of time to change the fatty acid pro-
file in the brain to a great extent. Feeding rats the same experimental diets for a
longer period, would give a better general idea of how the brain respond to the
dietary n-3 sources introduced in this work.
The different sources used in this trial contained remarkably different amounts
of EPA and DHA, and it was not possible to make eight diets with equal amounts
of long-chain n-3 PUFA from the sources used. For more acurate comparsions
between the different structural forms of the n-3 FA used in this work, more com-
parable amounts are needed in the diets. In order to achieve equal or comparable
amounts of EPA and DHA, or total amount of these two FA (EPA+DHA), fewer
diets must be used for comparisons.
In this experiment, the daily food intake did not differ significantly between the
different groups, however some of the groups have eaten more, and hence might
have gotten higher doses of the marine n-3 FA. To ensure that all animals con-
sume similiar amounts of the marine n-3 FAs, the amount of diet given should be
adjusted to the group/cage eating the least.
The brain appears to be more susceptible to dietary changes in the fatty acid pro-
file, at an early stage in development than when fully developed. The animals
used in this study were in young adulthood, and the dietary influence might have
been different in younger and/or older animals. It is therefore necessary to include
all 3 developmental stages (young, adulthood and aged) before making any con-
clusions on how the brain respond to the dietary marine n-3 FA presented in this
study.
Observations that n-3 FA affect gene expression of a number of genes in the brain
opens the way towards an understanding of the role these FA play in the function
of central nervous tissue. Until recently, it was belived that one of the major func-
tions of long-chain PUFA, particularly DHA, was to maintain proper biophysical
property and structural integrity of neural membranes. Kitajka and coworkers [34]
assigns an additional function to these FA, namely to control gene expression in
nervous tissue. According to the same group, it seems that in different tissues,
different genes respond differently to the same fatty acid, although each cell is
supplied with the identical genome. It would be of great interest to investigate the
diets used in this work at a molecular level. That is, how the dietary sources used
in this work affect the level of gene and/or mRNA expression in brain and other
tissues.
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n-3 FA are known to excert positive health effects in a number of diseases, and
there is an increasing interest in n-3 PUFA and mental health. In order to under-
stand cognitive changes presumably induced by n-3 PUFA, a better understanding
of the mechanisms in which the PUFA act in the brain is needed.
n-3 PUFA are distributed differently in brain regions in mice, and dietary effects
do not affect all regions similarly [137]. Chronic n-3 PUFA deficiency diet al-
ter the PUFA composition differently in brain regions in rats [42]. According to
Söderberget al. [12], DHA decrease excessively in the hippocampus of patients
with Alzheimer’s disease. The hippocampus is an anatomical well defined struc-
ture, and easy to separate from the rest of brain tissue. It would be therefore be
interesting to invegstigate the effect of the different diets introduced in this work
on hippocampus, as well as other brain regions i.e., cerebellum and frontal cortex.
A lot of research has been performed on total brain fatty acid compostition,
or different brain regions fatty acid composition, and fewer studies have investi-
gated dietary effects on different brain cell types. Jumpsenet al. [138] found that
feeding different diets produced larger changes in glial cells compared to neu-
ronal cells in young rats. The majority of DHA incorporated into the brain have
been found to be recovered in micosomal, synaptosomal and mitocondrial frac-
tions [139]. It would therefore be of great interest to investigate the accretion of
long-chain PUFA from different marine sources in different cell types and brain
fractions, i.e., asterocytes, glial cells, neuronal cell bodies, nerve cells, synapses,
synaptosomes.
Generally, fats characterized by gas-liquid chromatographt (GLC), as in this the-
sis, will only provide the fatty acid profile without any information on species
compostition or location of FA. A more detailed description, including fatty acid
profile in phospholipid subclasses (PE, PC and PI) or regiospecific location of the
fatty acids in TAG, would be of interest in order to get a more accurate view of
the dietary changes occuring in the fatty acid profile. Especially since it is know
that DHA content varies considerably in the different phospholipid species, and
DHA is especially abundant in phosphatidylserine and phosphatidylethanolamine
of membranes in general [115, 120], in brain gray matter [29], and in synaptoso-
mal membranes [13]. Moreover, it has also been shown [37, 138] that the different
phospholipid species resond differently to dietary changes.
Studies report that increasing levels of DHA in the brain result in decreasing lev-
els of DPA n-6 [21, 22, 37, 122]. DPA n-3 was not investigated in this work, but
should be included in further studies.
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The relative amount and absolute amount found incorporated differed for some
FA, and in some tissues. For better understanding the amount of FA, and rate at
which they are incorporated, absolute amounts must be used, especially when us-
ing diets varying in the amounts of spesific FA, i.e., 18 : 2n-6 in this work.
In terms of animal models, it needs to be recognized that some mammals provide
better models of nutritional studies. Differences in retinogenesis, the develop-
ment of retinal function, has been reported to be more similar in man and guinea
pig, than it is in rats. Moreover, the rate of conversion of 18 carbon PUFA to
long-chain metabolites is slower in guinea pig than rats and may be more closely
related to the rate of conversion seen for humans. According to Abedinet al. [22]
guinea pig is a better animal model than rat when examining tissue DHA levels
and physiological function resulting from dietary manipulation of n-3 PUFA. Ri-
oux et al. [70] report of diet induced changes in FA compostition in a studie with
piglets, a species that share many similarities in physiology and lipid metabolism
with humans.
Diets rich in marine n-3 resulted, in some of the animals, in fatty liver. This
needs further investigation, in order to establish the cause of increased fatty liver






The basal mix preparation was kindly prepared by technician Åse Heltveit. Its
content is shown in table 5.1.
Table 5.1: Basal mix
Basal mix Amount











The marine phospholipids used in this experiment was extracted from Capelin
(Mallotus villosus) roe. The specifications of this product is shown in table 5.2 as
given by EXIMO AS (Tromsø, Norway)
Table 5.2: Specification of Marine PL
Specification Result1
Appearance Orange/brown
Phospholipids2,3 50% of total lipids
- Lyso Phosphatidylcholine 2-4%
- Phosphatidylethanolamine 10-15%
- Lyso Phosphatidylethanolamine 1-3%
Neutral lipids 40-50% of total lipids
- Triacylglycerol 15-30%
- Cholesterol 10%
- Free Fatty Acids 10-12%
1Analytical values are based on dry weight material.
2Total Phospholipids are caluculated from measurements of total phosphorous
3Quantitative analyses of individual lipid classes by HPTLC
The fatty acid composition of the same product is shown in table 5.3. Also as
given by EXIMO AS (Tromsø, Norway)
Table 5.3: Fatty Acid Composition of Marine PL
Fatty Acid % of total
Myristic ( 14 : 0) 4.2
Palmitic(16 : 0) 23.1
Stearic (18 : 0) 2.9
Oleic (18 : 1n-9) 6.9
Linolei(18 : 2n-6) 1.0
Linolenic (18 : 3n-3) 0.6
Aracidonic (20 : 4n-6) 1.1
Eicosapentaenoic (EPA,20 : 5n-3) 9.6
Docosahexaenoic (DHA,22 : 6n-3) 25.1
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